{"id":30975436,"title":"Group Sequential Methods in the Design and Analysis of Clinical Trials","authors":["Stuart J Pocock"],"_abstract":"ABSTRACT SUMMARY In clinical trials with sequential patient entry, fixed sample size designs are unjustified on ethical grounds and sequential designs are often impracticable. One solution is a group sequential design dividing patient entry into a number of equal-sized groups so that the decision to stop the trial or continue is based on repeated significance tests of the accumulated data after each group is evaluated. Exact results are obtained for a trial with two treatments and a normal response with known variance. The design problem of determining the required size and number of groups is also considered. Simulation shows that these normal results may be adapted to other types of response data. An example shows that group sequential designs can sometimes be statistically superior to standard sequential designs.","cited_in":[{"id":283512208,"url":"https://www.researchgate.net/publication/283512208_Optimal_adaptive_sequential_designs_for_crossover_bioequivalence_studies"},{"id":272098264,"url":"https://www.researchgate.net/publication/272098264_Modifications_of_sequential_designs_in_bioequivalence_trials_C_Zheng_L_Zhao_and_J_Wang"},{"id":271668759,"url":"https://www.researchgate.net/publication/271668759_A_Novel_Powerful_Joint_Analysis_with_Data_Fusion_in_Two-stage_Case-control_Genome-wide_Association_Studies"},{"id":265645016,"url":"https://www.researchgate.net/publication/265645016_Pentoxifylline_vs_corticosteroid_to_treat_severe_alcoholic_hepatitis_A_randomised_non-inferiority_open_trial"},{"id":261369656,"url":"https://www.researchgate.net/publication/261369656_Flexible_Stopping_Boundaries_When_Changing_Primary_Endpoints_After_Unblinded_Interim_Analyses"},{"id":267331634,"url":"https://www.researchgate.net/publication/267331634_The_Effect_of_Horizontal_Eye_Movements_on_Free_Recall_A_Preregistered_Adversarial_Collaboration"},{"id":286827814,"url":"https://www.researchgate.net/publication/286827814_Determination_of_Sample_Size_for_Two_Stage_Sequential_Designs_in_Bioequivalence_Studies_under_2x2_Crossover_Design"},{"id":262342836,"url":"https://www.researchgate.net/publication/262342836_Statistical_issues_and_challenges_in_immuno-oncology"},{"id":255974645,"url":"https://www.researchgate.net/publication/255974645_The_Role_of_the_Upper_Sample_Size_Limit_in_Two-Stage_Bioequivalence_Designs"},{"id":236235190,"url":"https://www.researchgate.net/publication/236235190_Austerity_in_MCMC_Land_Cutting_the_Metropolis-Hastings_Budget"},{"id":236204945,"url":"https://www.researchgate.net/publication/236204945_Stop_Antibiotics_on_guidance_of_Procalcitonin_Study_SAPS_A_randomised_prospective_multicenter_investigator-initiated_trial_to_analyse_whether_daily_measurements_of_procalcitonin_versus_a_standard-of-c"},{"id":258232105,"url":"https://www.researchgate.net/publication/258232105_Sample_size_determination_for_group_sequential_test_under_fractional_Brownian_motion"},{"id":231214976,"url":"https://www.researchgate.net/publication/231214976_A_new_futility_test_approach_in_clinical_interim_data_monitoring"},{"id":221732755,"url":"https://www.researchgate.net/publication/221732755_A_Hybrid_Geometric_Phase_IIIII_Clinical_Trial_Design_based_on_Treatment_Failure_Time_and_Toxicity"},{"id":49824619,"url":"https://www.researchgate.net/publication/49824619_Additional_results_for_'Sequential_design_approaches_for_bioequivalence_studies_with_crossover_designs'"},{"id":51094405,"url":"https://www.researchgate.net/publication/51094405_Exploring_the_benefits_of_adaptive_sequential_designs_in_time-to-event_endpoint_settings"},{"id":227369052,"url":"https://www.researchgate.net/publication/227369052_Group_Sequential_Methods_and_Software_Applications"},{"id":51138493,"url":"https://www.researchgate.net/publication/51138493_Adaptive_designs_in_clinical_trials"},{"id":254441020,"url":"https://www.researchgate.net/publication/254441020_A_Markov_Test_for_Alpha"},{"id":50597301,"url":"https://www.researchgate.net/publication/50597301_Predicted_Interval_Plots_PIPS_A_Graphical_Tool_for_Data_Monitoring_of_Clinical_Trials"},{"id":223217818,"url":"https://www.researchgate.net/publication/223217818_Review_of_approaches_to_evaluate_the_effectiveness_of_weed_biological_control_agents"},{"id":232845914,"url":"https://www.researchgate.net/publication/232845914_Approximately_Optimal_Continuous_Stopping_Boundaries_in_a_One-Sided_Standard_Sequential_Test"},{"id":23570532,"url":"https://www.researchgate.net/publication/23570532_Who's_minding_the_data_Data_Monitoring_Committees_in_clinical_cancer_trials"},{"id":1924029,"url":"https://www.researchgate.net/publication/1924029_Sequential_nonparametrics_and_semiparametrics_Theory_implementation_and_applications_to_clinical_trials"},{"id":5910934,"url":"https://www.researchgate.net/publication/5910934_Implementing_type_I_type_II_error_spending_for_two-sided_group_sequential_designs"},{"id":222156676,"url":"https://www.researchgate.net/publication/222156676_Burden_of_bioinformatics_in_medical_research_Statistical_perspectives_and_controversies"},{"id":250146086,"url":"https://www.researchgate.net/publication/250146086_P-Value_calculation_for_multi-stage_additive_tests"},{"id":6399227,"url":"https://www.researchgate.net/publication/6399227_Alternative_designs_of_phase_II_trials_considering_response_and_toxicity"},{"id":6595681,"url":"https://www.researchgate.net/publication/6595681_Milder_ovarian_stimulation_for_in_vitro_fertilization_reduces_aneuploidy_in_the_human_preimplantation_embryo_a_randomized_controlled_trial_Hum_Reprod"},{"id":223038265,"url":"https://www.researchgate.net/publication/223038265_Bayes_optimal_sequential_trial_designs"},{"id":6643836,"url":"https://www.researchgate.net/publication/6643836_Multistage_Evaluation_of_Measurement_Error_in_a_Reliability_Study"},{"id":7732353,"url":"https://www.researchgate.net/publication/7732353_A_Note_on_P-Values_under_Group_Sequential_Testing_and_Nonproportional_Hazards"},{"id":7997036,"url":"https://www.researchgate.net/publication/7997036_Bayesian_Monitoring_of_Clinical_Trials_with_Failure-Time_Endpoints"},{"id":253809630,"url":"https://www.researchgate.net/publication/253809630_GROUP_SEQUENTIAL_TEST_OF_NON-PARAMETRIC_STATISTICS_FOR_SURVIVAL_DATA"},{"id":245496060,"url":"https://www.researchgate.net/publication/245496060_Principles_of_Optimal_Sequential_Planning"},{"id":8500676,"url":"https://www.researchgate.net/publication/8500676_Conditional_Bias_of_Point_Estimates_Following_a_Group_Sequential_Test"},{"id":8690564,"url":"https://www.researchgate.net/publication/8690564_Flexible_Implementations_of_Group_Sequential_Stopping_Rules_Using_Constrained_Boundaries"},{"id":10708334,"url":"https://www.researchgate.net/publication/10708334_Efficacy_and_safety_of_an_extract_of_Pelargonium_sidoides_EPs_7630_in_adults_with_acute_bronchitis"},{"id":10603257,"url":"https://www.researchgate.net/publication/10603257_Interim_analyses_of_data_as_they_accumulate_in_laboratory_experimentation"},{"id":10979790,"url":"https://www.researchgate.net/publication/10979790_Seamlessly_expanding_a_randomized_Phase_II_trial_to_Phase_III"},{"id":10999137,"url":"https://www.researchgate.net/publication/10999137_Triangular_test_applied_to_the_clinical_trial_of_azithromycin_against_relapses_in_Plasmodium_vivax_infections"},{"id":2914616,"url":"https://www.researchgate.net/publication/2914616_Optimal_Time-Adaptive_Repeated_Significance_Tests"},{"id":228740757,"url":"https://www.researchgate.net/publication/228740757_Interim_Monitoring_of_Group_Sequential_Trials_Using_Spending_Functions_for_the_Type_I_and_Type_II_Error_Probabilities"},{"id":5182181,"url":"https://www.researchgate.net/publication/5182181_Some_sequential-type_conditional_tests_in_clinical_trials_based_on_generalized_randomized_play-the-winner_rule"},{"id":12019898,"url":"https://www.researchgate.net/publication/12019898_Sequential_Methods_for_Comparing_Years_of_Life_Saved_in_the_Two-Sample_Censored_Data_Problem"},{"id":240624196,"url":"https://www.researchgate.net/publication/240624196_DELAYED_RESPONSE_IN_BIVARIATE_SET_UP_USING_GIBBS_SAMPLER"},{"id":223697855,"url":"https://www.researchgate.net/publication/223697855_Multiple_comparisons_in_interim_analysis"},{"id":2483916,"url":"https://www.researchgate.net/publication/2483916_Group_Sequential_Procedures_for_Poisson_Process_Data_with_Frailty"},{"id":4893364,"url":"https://www.researchgate.net/publication/4893364_Exact_calculations_for_the_repeated_many-one_test"},{"id":222267810,"url":"https://www.researchgate.net/publication/222267810_A_simulation_program_for_adaptive_two_stage_designs"},{"id":262872805,"url":"https://www.researchgate.net/publication/262872805_Multistage_bandit_problems"},{"id":4890466,"url":"https://www.researchgate.net/publication/4890466_Use_of_the_fast_Fourier_transform_algorithm_in_the_calculation_of_the_operating_characteristics_of_group_sequential_clinical_trials"},{"id":266554610,"url":"https://www.researchgate.net/publication/266554610_Group_sequential_methods_for_survival_data_using_partial_score_processes_with_covariate_adjustment"},{"id":223619791,"url":"https://www.researchgate.net/publication/223619791_Group_sequential_designs_for_one-sided_and_two-sided_hypothesis_testing_with_provision_for_early_stopping_in_favor_of_the_null_hypothesis_J_Statist_Plan_Infer_421-219-35"},{"id":24052153,"url":"https://www.researchgate.net/publication/24052153_Robust_tests_in_group_sequential_analysis_One-_and_two-sided_hypotheses_in_the_linear_model"},{"id":223375965,"url":"https://www.researchgate.net/publication/223375965_Planning_sequential_clinical_trials_A_review"},{"id":20480231,"url":"https://www.researchgate.net/publication/20480231_Symmetric_Group_Sequential_Test_Designs"},{"id":232354825,"url":"https://www.researchgate.net/publication/232354825_A_sequential_elimination_procedure_for_choosing_the_best_populations_based_on_multiple_testing"},{"id":31908221,"url":"https://www.researchgate.net/publication/31908221_STATISTICAL_INFERENCE_PROCESSES_AND_THEIR_PROPERTIES_BASED_ON_KNOWLEDGE_FUNCTIONS_IN_NISAN_SYSTEM"},{"id":268353321,"url":"https://www.researchgate.net/publication/268353321_Curtailed_Online_Boosting"},{"id":266462870,"url":"https://www.researchgate.net/publication/266462870_Self-designing_group_sequential_trials_to_minimize_expected_sample_size"},{"id":254408846,"url":"https://www.researchgate.net/publication/254408846_A_claim_for_sequential_designs_of_experiments"},{"id":267297004,"url":"https://www.researchgate.net/publication/267297004_Uber_die_Durchfuhrung_Gruppen-sequentieller_Tests_fur_das_Zweistichprobenproblem_basierend_auf_robusten_Lokations-und_Skalenschatzern_mit_SAS"},{"id":242275343,"url":"https://www.researchgate.net/publication/242275343_TRIFLUSAL_NA_PREVENCAO_SECUNDARIA_DE_DAC_E_OUTRAS_INDICACOES_EM_DOENCAS_CARDIOVASCULARES"},{"id":237611141,"url":"https://www.researchgate.net/publication/237611141_On_Lean_Body_Mass_Weight_Body_Fat_and_Quality_Of_Life_in_Patients_with_Solid_Tumors_and_Weight_Loss_Receiving_Chemotherapy"},{"id":253732805,"url":"https://www.researchgate.net/publication/253732805_Group_Sequential_Analysis_Using_the_New_SEQDESIGN_and_SEQTEST_Procedures"},{"id":252233689,"url":"https://www.researchgate.net/publication/252233689_Preprint_of_the_Book_Chapter_Bayesian_Versus_Frequentist_Inference"},{"id":242571640,"url":"https://www.researchgate.net/publication/242571640_Constrained_Boundary_Monitoring_for_Group_Sequential_Clinical_Trials"},{"id":237268627,"url":"https://www.researchgate.net/publication/237268627_Comprehensive_Cancer_Center_of_Wake_Forest_University_CCOP_Research_Base_CCCWFU_97202_IND_71915_A_Randomized_Double-Blind_Placebo-Controlled_Study_of_Oral_Coenzyme_Q10_to_Relieve_Self_Reported_Cancer_"},{"id":239548484,"url":"https://www.researchgate.net/publication/239548484_Effect_of_All_Transretinoic_Acid_in_Newly_Diagnosed_Acute_Promyelocytic_Leukemia_Results_of_a_Multicenter_Randomized_Trial"},{"id":239529562,"url":"https://www.researchgate.net/publication/239529562_Comprehensive_Cancer_Center_of_Wake_Forest_University_CCOP_Research_Base_-_CCCWFU_97102_A_Phase_III_Randomized_Study_Comparing_the_Effects_of_Oxandrolone_OxandrinRand_Megestrol_Acetate_Megace_R_On_Lea"},{"id":242548473,"url":"https://www.researchgate.net/publication/242548473_Biometrie_5_Auflage_als_eBook"},{"id":255608636,"url":"https://www.researchgate.net/publication/255608636_Continuous_Positive_Airway_Pressure_for_Treatment_of_Postoperative_Hypoxemia"},{"id":228944700,"url":"https://www.researchgate.net/publication/228944700_Powervergabe_bei_Klinischen_Studien_mit_flexiblen_Designs"},{"id":35145724,"url":"https://www.researchgate.net/publication/35145724_Intervalles_de_confiance_pour_une_difference_de_deux_proportions_ressource_electronique"},{"id":28315017,"url":"https://www.researchgate.net/publication/28315017_Disenos_adaptativos_para_ensayos_clinicos_fase_II_o_III_en_pacientes_con_cancer_en_Cuba"},{"id":46644437,"url":"https://www.researchgate.net/publication/46644437_Application_and_efficiency_of_sequential_tests_in_matched_case-control_studies"},{"id":266012852,"url":"https://www.researchgate.net/publication/266012852_Adaptive_Group_Sequential_Three-Arm_Trials_Including_Placebo_for_Showing_Noninferiority_of_a_New_Drug"},{"id":29756925,"url":"https://www.researchgate.net/publication/29756925_Wirksamkeit_von_Cromoglycinsaure_und_Reproterol_im_Vergleich_zu_Montelukast_auf_das_Anstrengungsasthma_von_Kindern_und_Jugendlichen"},{"id":267303201,"url":"https://www.researchgate.net/publication/267303201_The_Use_of_a_Bayesian_Confidence_Propagation_Neural_Network_in_Pharmacovigilance"},{"id":265006765,"url":"https://www.researchgate.net/publication/265006765_User's_Guide_IV"},{"id":35318891,"url":"https://www.researchgate.net/publication/35318891_Analyzing_multiple_endpoints_with_a_two-stage_group_sequential_design_in_clinical_trials_microform"},{"id":41527310,"url":"https://www.researchgate.net/publication/41527310_Modelisation_statistique_pour_la_recherche_de_genes_differentiellement_exprimes_modeles_de_variance-covariance_analyse_sequentielle_et_meta-analyse"},{"id":267700166,"url":"https://www.researchgate.net/publication/267700166_A_FRAMEWORK_FOR_DESIGN_OF_TWO-STAGE_ADAPTIVE_PROCEDURES"},{"id":22645622,"url":"https://www.researchgate.net/publication/22645622_A_Multiple_Test_Procedure_for_Clinical_Trials"},{"id":15825873,"url":"https://www.researchgate.net/publication/15825873_Group_sequential_methods_for_cohort_and_case-control_studies"},{"id":31291942,"url":"https://www.researchgate.net/publication/31291942_Group_Sequential_Methods_for_Clinical_Trials_with_a_One-Sided_Hypothesis"},{"id":15872040,"url":"https://www.researchgate.net/publication/15872040_Design_and_methodological_considerations_in_the_National_Cooperative_Gallstone_Study_A_multicenter_clinical_trial"},{"id":16012177,"url":"https://www.researchgate.net/publication/16012177_On_choosing_the_number_of_interim_analyses_in_clinical_trials"},{"id":16115808,"url":"https://www.researchgate.net/publication/16115808_Interim_Analyses_for_Randomized_Clinical_Trials_The_Group_Sequential_Approach"},{"id":16130514,"url":"https://www.researchgate.net/publication/16130514_Early_stopping_in_the_two-sample_problem_for_bounded_variables"},{"id":16115807,"url":"https://www.researchgate.net/publication/16115807_Fleming_TROne_sample_multiple_testing_procedure_for_phase_II_trials_Biometrics_38_143-151"},{"id":243082580,"url":"https://www.researchgate.net/publication/243082580_Group_Sequential_Methods_for_Clinical_Trials_Allowing_Early_Acceptance_of_H_o_and_Incorporating_Costs"},{"id":30941918,"url":"https://www.researchgate.net/publication/30941918_P_Values_for_Test_Using_a_Repeated_Significance_Test_Design"},{"id":16450425,"url":"https://www.researchgate.net/publication/16450425_A_case_report_of_data_monitoring_experience_the_Nocturnal_Oxygen_Therapy_Trial"},{"id":241721683,"url":"https://www.researchgate.net/publication/241721683_Two-Sample_Repeated_Significance_Tests_Based_on_the_Modified_Wilcoxon_Statistic"},{"id":222004463,"url":"https://www.researchgate.net/publication/222004463_Monitoring_rules_for_stopping_accrual_in_comparative_survival_studies"},{"id":233293367,"url":"https://www.researchgate.net/publication/233293367_A_Survey_Of_Two_Stage_Tests_Of_Hypotheses_Theory_And_Application"},{"id":16618986,"url":"https://www.researchgate.net/publication/16618986_Statistical_strategies_for_animal_conservation"},{"id":16339462,"url":"https://www.researchgate.net/publication/16339462_Critical_Issues_in_the_Conduct_and_Interpretation_of_Clinical_Trials"},{"id":277396114,"url":"https://www.researchgate.net/publication/277396114_The_Assessment_of_Subjective_Opinion_and_Its_Use_in_Relation_to_Stopping_Rules_for_Clinical_Trials"},{"id":16328373,"url":"https://www.researchgate.net/publication/16328373_Group_Sequential_Clinical_Trials_with_Triangular_Continuation_Regions"},{"id":16548461,"url":"https://www.researchgate.net/publication/16548461_Stopping_rules_for_clinical_trials"},{"id":16854133,"url":"https://www.researchgate.net/publication/16854133_Healing_of_benign_gastric_ulcer_with_low-dose_antacid_or_cimetidine_A_double-blind_randomized_placebo-controlled_trial"},{"id":31503518,"url":"https://www.researchgate.net/publication/31503518_Discrete_Sequential_Boundaries_for_Clinical_Trials"},{"id":238866463,"url":"https://www.researchgate.net/publication/238866463_Incorporating_scientific_ethical_and_economic_considerations_into_the_design_of_clinical_trials_in_the_pharmaceutical_industry_A_sequential_approach"},{"id":243048856,"url":"https://www.researchgate.net/publication/243048856_An_overview_of_sequential_methods_and_their_application_in_clinical_trials"},{"id":238866465,"url":"https://www.researchgate.net/publication/238866465_Stopping_guidelines_vs_stopping_rules_A_practitioner's_point_of_view"},{"id":238866461,"url":"https://www.researchgate.net/publication/238866461_More_flexible_sequential_and_non-sequential_designs_in_long-term_clinical_trial"},{"id":243048860,"url":"https://www.researchgate.net/publication/243048860_Monitoring_long-term_clinical_trials_for_beneficial_and_adverse_treatment_effects"},{"id":254330518,"url":"https://www.researchgate.net/publication/254330518_Sensitivity_of_Bayes_Inference_with_Data-Dependent_Stopping_Rules"},{"id":38359096,"url":"https://www.researchgate.net/publication/38359096_Sequential_Linear_Rank_Tests_for_Two-Sample_Censored_Survival_Data"},{"id":16719175,"url":"https://www.researchgate.net/publication/16719175_Multicentre_trial_on_feeding_low_birth_weight_infants_Effects_of_diet_on_early_growth"},{"id":16668445,"url":"https://www.researchgate.net/publication/16668445_Can_early_stopping_procedures_impact_significantly_on_the_efficiency_of_clinical_trials_without_serious_loss_of_information"},{"id":229831843,"url":"https://www.researchgate.net/publication/229831843_The_randomized_clinical_trial"},{"id":16678555,"url":"https://www.researchgate.net/publication/16678555_Exact_Confidence_Intervals_Following_a_Group_Sequential_Test"},{"id":16678548,"url":"https://www.researchgate.net/publication/16678548_Stopping_Rules_for_Clinical_Trials_Incorporating_Clinical_Opinion"},{"id":16678554,"url":"https://www.researchgate.net/publication/16678554_Two-Stage_Clinical_Trial_Stopping_Rules"},{"id":16699658,"url":"https://www.researchgate.net/publication/16699658_On_the_LOD_score_method_in_linkage_analysis"},{"id":233018827,"url":"https://www.researchgate.net/publication/233018827_A_simplified_two_sample_sequential_t-Test"},{"id":16812750,"url":"https://www.researchgate.net/publication/16812750_A_randomized_controlled_trial_of_cefaclor_compared_with_trimethoprim-sulfamethoxazole_for_treatment_of_acute_otitis_media"},{"id":242938855,"url":"https://www.researchgate.net/publication/242938855_The_Application_of_Hunter's_Inequality_in_Simultaneous_Testing"},{"id":16677076,"url":"https://www.researchgate.net/publication/16677076_Design_for_group_sequential_tests"},{"id":227925310,"url":"https://www.researchgate.net/publication/227925310_Treatment_allocation_methods_A_review"},{"id":19322652,"url":"https://www.researchgate.net/publication/19322652_A_FORTRAN_program_for_the_design_and_analysis_of_sequential_clinical_trials"},{"id":19135262,"url":"https://www.researchgate.net/publication/19135262_Repeated_Significance_Tests_for_Clinical_Trials_with_a_Fixed_Number_of_Patients_and_Variable_Follow-Up"},{"id":227662080,"url":"https://www.researchgate.net/publication/227662080_Interim_analysis_in_clinical_trials_Classical_vs_Bayesian_approaches"},{"id":233444017,"url":"https://www.researchgate.net/publication/233444017_Bayesian_sequential_methods_for_choosing_the_better_of_two_binomial_population"},{"id":233038287,"url":"https://www.researchgate.net/publication/233038287_Approximating_boundary_crossing_probabilities_with_applications_to_sequential_tests_Seq_Anal_5_37-72"},{"id":242939125,"url":"https://www.researchgate.net/publication/242939125_Sequential_Analysis_of_Survival_Times_in_Clinical_Trials"},{"id":19085963,"url":"https://www.researchgate.net/publication/19085963_Early_decision_in_clinical_trials_when_the_treatment_differences_are_small_experience_of_a_controlled_trial_in_head_trauma_Contr_Clin_Trial_64280-288_DOI_1010160197-24568590104-7"},{"id":242939171,"url":"https://www.researchgate.net/publication/242939171_Two_Stage_Sampling_for_Simultaneously_Testing_Main_and_Side_Effects_in_Clinical_Trials"},{"id":223049638,"url":"https://www.researchgate.net/publication/223049638_Monitoring_boundaries_for_adverse_effects_in_long-term_clinical_trials"},{"id":19206150,"url":"https://www.researchgate.net/publication/19206150_Confidence_intervals_following_group_sequential_tests"},{"id":38360006,"url":"https://www.researchgate.net/publication/38360006_Boundary_Crossing_Probabilities_and_Statistical_Applications_Ann_Statist_14_361-404"},{"id":20067273,"url":"https://www.researchgate.net/publication/20067273_Multipoint_linkage_analysis"},{"id":19398165,"url":"https://www.researchgate.net/publication/19398165_A_clinical_trial_with_an_interim_analysis"},{"id":19398164,"url":"https://www.researchgate.net/publication/19398164_A_simulation_study_of_three_sequential_methods_for_the_comparison_of_two_treatment_groups_when_the_response_criterion_is_censored"},{"id":254086108,"url":"https://www.researchgate.net/publication/254086108_Interim_Analyses_in_Randomized_Clinical_Trials"},{"id":19628125,"url":"https://www.researchgate.net/publication/19628125_A_randomized_controlled_trial_of_amoxicillin_plus_clavulanate_compared_with_cefaclor_for_treatment_of_acute_otitis_media"},{"id":19357167,"url":"https://www.researchgate.net/publication/19357167_p-Value_and_power_computations_in_multiple_look_trials"},{"id":20720469,"url":"https://www.researchgate.net/publication/20720469_Glycerol_and_dextran_combined_in_the_therapy_of_acute_stroke_A_placebo-controlled_double-blind_trial_with_a_planned_interim_analysis"},{"id":243082753,"url":"https://www.researchgate.net/publication/243082753_Tests_for_a_Change-Point"},{"id":243082716,"url":"https://www.researchgate.net/publication/243082716_Efficient_Group_Sequential_Tests_with_Unpredictable_Group_Sizes"},{"id":38360140,"url":"https://www.researchgate.net/publication/38360140_Asymptotic_Expansions_in_Anscombe's_Theorem_for_Repeated_Significance_Tests_and_Estimation_after_Sequential_Testing"},{"id":38360141,"url":"https://www.researchgate.net/publication/38360141_Sample_Size_Savings_for_Curtailed_One-Sample_Nonparametric_Tests_for_Location_Shift"},{"id":243082712,"url":"https://www.researchgate.net/publication/243082712_Design_and_Analysis_of_Group_Sequential_Tests_Based_on_the_Type_I_Error_Spending_Rate_Function"},{"id":19595229,"url":"https://www.researchgate.net/publication/19595229_Approximately_Optimal_One-Parameter_Boundaries_for_Group_Sequential_Trials"},{"id":19546220,"url":"https://www.researchgate.net/publication/19546220_Effects_of_overviews_of_early_stopping_rules_for_clinical_trials"},{"id":20177484,"url":"https://www.researchgate.net/publication/20177484_Review_clinical_trials_in_peptic_ulcer_disease-problems_of_methodology_and_interpretation"},{"id":19552439,"url":"https://www.researchgate.net/publication/19552439_Optimal_restricted_two-stage_designs"},{"id":19475657,"url":"https://www.researchgate.net/publication/19475657_Monitoring_distributional_assumptions_and_early_stopping_for_a_prospective_clinical_trial_using_Monte_Carlo_simulation"},{"id":19835629,"url":"https://www.researchgate.net/publication/19835629_Practical_aspects_in_data_monitoring_A_brief_review"},{"id":19497749,"url":"https://www.researchgate.net/publication/19497749_The_Analysis_Of_Multiple_Endpoints_In_Clinical_Trials"},{"id":19729507,"url":"https://www.researchgate.net/publication/19729507_Confidence_Intervals_Following_Group_Sequential_Tests_in_Clinical_Trials"},{"id":227967414,"url":"https://www.researchgate.net/publication/227967414_The_application_of_a_two-stage_design_for_clinical_trials_in_patients_with_recurrent_head_and_neck_cancer"},{"id":19797307,"url":"https://www.researchgate.net/publication/19797307_One-Sided_Sequential_Stopping_Boundaries_for_Clinical_Trials_A_Decision-_Theoretic_Approach"},{"id":227915548,"url":"https://www.researchgate.net/publication/227915548_Optimal_two-stage_designs_for_clinical_trials_with_binary_response"},{"id":31435604,"url":"https://www.researchgate.net/publication/31435604_Sequential_testing_in_clinical_trials_with_repeated_measurements"},{"id":20109619,"url":"https://www.researchgate.net/publication/20109619_Androgen_priming_and_chemotherapy_in_advanced_prostate_cancer_Evaluation_of_determinants_of_clinical_outcome"},{"id":19924246,"url":"https://www.researchgate.net/publication/19924246_Hughes_MD_Pocock_SJ_Stopping_rules_and_estimation_problems_in_clinical_trials"},{"id":246584500,"url":"https://www.researchgate.net/publication/246584500_Inference_and_decision_in_clinical_trials1"},{"id":20097366,"url":"https://www.researchgate.net/publication/20097366_Statistical_Considerations_for_Performing_Multiple_Tests_in_a_Single_Experiment_6_Testing_Accumulating_Data_Repeatedly_Over_Time"},{"id":20513186,"url":"https://www.researchgate.net/publication/20513186_Approaches_to_Monitoring_Clinical_Trials"},{"id":20436290,"url":"https://www.researchgate.net/publication/20436290_Confidence_Intervals_for_a_Normal_Mean_Following_a_Group_Sequential_Test"},{"id":20498178,"url":"https://www.researchgate.net/publication/20498178_The_impact_that_group_sequential_tests_would_have_made_on_ECOG_clinical_trials"},{"id":20389885,"url":"https://www.researchgate.net/publication/20389885_Point_Estimation_Following_Group_Sequential_Tests"},{"id":254286895,"url":"https://www.researchgate.net/publication/254286895_Design_of_Group_Sequential_Clinical_Trials_with_Multiple_Endpoints"},{"id":264487623,"url":"https://www.researchgate.net/publication/264487623_Group_sequential_procedures_-_Calendar_vs_information_time"},{"id":20366359,"url":"https://www.researchgate.net/publication/20366359_Changing_Frequency_of_Interim_Analysis_in_Sequential_Monitoring"},{"id":243049275,"url":"https://www.researchgate.net/publication/243049275_Hardy_R_J_'Upper_bounds_for_type_I_and_type_II_error_rates_in_conditional_power_calculations'_Communications_in_Statistics_1910_3571-3584"},{"id":243049497,"url":"https://www.researchgate.net/publication/243049497_A_bayesian_group_sequential_analysis_procedure"},{"id":233090643,"url":"https://www.researchgate.net/publication/233090643_The_double_triangular_test_A_sequential_test_for_the_two-sided_alternative_with_early_stopping_under_the_null_hypothesis"},{"id":20465444,"url":"https://www.researchgate.net/publication/20465444_Analyses_of_group_sequential_clinical_trials"},{"id":20550184,"url":"https://www.researchgate.net/publication/20550184_Practical_problems_in_interim_analyses_with_particular_regard_to_estimation"},{"id":241646067,"url":"https://www.researchgate.net/publication/241646067_Issues_in_Planning_Interim_Analyses"},{"id":20804660,"url":"https://www.researchgate.net/publication/20804660_Study_Duration_for_Clinical_Trials_with_Survival_Response_and_Early_Stopping_Rule"},{"id":20960753,"url":"https://www.researchgate.net/publication/20960753_Antiplatelet_treatment_with_ticlopidine_in_unstable_angina_A_controlled_multicenter_clinical_trial_The_Studio_della_Ticlopidina_nell'Angina_Instabile_Group"},{"id":20938254,"url":"https://www.researchgate.net/publication/20938254_Application_of_the_triangular_test_to_Phase_II_cancer_clinical_trials"},{"id":20938242,"url":"https://www.researchgate.net/publication/20938242_CTS_A_clinical_trials_simulator"},{"id":20938252,"url":"https://www.researchgate.net/publication/20938252_Early_methodological_developments_for_clinical_trials_at_the_National_Heart_Lung_and_Blood_Institute"},{"id":20912152,"url":"https://www.researchgate.net/publication/20912152_Statistical_interim_monitoring_of_the_Cardiac_Arrhythmia_Suppression_Trial"},{"id":20914485,"url":"https://www.researchgate.net/publication/20914485_Implementation_of_Group_Sequential_Logrank_Tests_in_a_Maximum_Duration_Trial"},{"id":20931652,"url":"https://www.researchgate.net/publication/20931652_Recruitment_follow-up_and_analysis_times_in_clinical_trials_of_cancer_treatment_A_case_study"},{"id":20877960,"url":"https://www.researchgate.net/publication/20877960_An_improved_approximation_for_calculation_of_confidence_intervals_after_a_sequential_clinical_trial"},{"id":20875313,"url":"https://www.researchgate.net/publication/20875313_Group_sequential_design_using_a_family_of_Type_I_error_probability_spending_functions"},{"id":232985114,"url":"https://www.researchgate.net/publication/232985114_A_note_on_the_asymptotic_joint_distribution_of_successive_Mantel-Haenszel_estimates_of_the_odds_ratio_based_on_accumulating_data"},{"id":230540313,"url":"https://www.researchgate.net/publication/230540313_Stopping_Rules_for_Clinical_Trials_Implicitly_Incorporating_Safety_Information"},{"id":228053093,"url":"https://www.researchgate.net/publication/228053093_Monitoring_a_randomized_clinical_trial_for_futility_The_north-norwegian_lidocaine_intervention_trial"},{"id":21157383,"url":"https://www.researchgate.net/publication/21157383_Systolic_Hypertension_of_the_Elderly_Program_SHEP_Part_10_Analysis"},{"id":21160946,"url":"https://www.researchgate.net/publication/21160946_Risk_monitoring_of_randomized_trials_in_emergency_medicine_Experience_of_the_Brain_Resuscitation_Clinical_Trial_II"},{"id":223918992,"url":"https://www.researchgate.net/publication/223918992_Operational_aspects_of_terminating_randomization_in_the_multicenter_trial_of_cryotherapy_for_retinopathy_of_prematurity"},{"id":21147948,"url":"https://www.researchgate.net/publication/21147948_Randomized_placebo-controlled_trial_of_human_surfactant_given_at_birth_versus_rescue_administration_in_very_low_birth_weight_infants"},{"id":21278769,"url":"https://www.researchgate.net/publication/21278769_Some_extensions_to_a_new_approach_for_interim_analysis_in_clinical_trials"},{"id":21323545,"url":"https://www.researchgate.net/publication/21323545_Multiple_testing_in_clinical_trials"},{"id":21278767,"url":"https://www.researchgate.net/publication/21278767_Interim_analysis_in_clinical_trials"},{"id":21334742,"url":"https://www.researchgate.net/publication/21334742_Statistical_aspects_of_research_methodology"},{"id":241646167,"url":"https://www.researchgate.net/publication/241646167_Bayesian_Methods_in_Phase_III_Trials"},{"id":21504946,"url":"https://www.researchgate.net/publication/21504946_Termination_of_the_Department_of_Veterans_Affairs_Cooperative_Study_of_steroid_therapy_for_systemic_sepsis"},{"id":247492150,"url":"https://www.researchgate.net/publication/247492150_Sequential_Comparison_of_Changes_With_Repeated_Measurements_Data"},{"id":21390288,"url":"https://www.researchgate.net/publication/21390288_Amery_A_Birkenhager_W_Bulpitt_CJ_et_al_Syst-Eur_A_multicentre_trial_on_the_treatment_of_isolated_systolic_hypertension_in_the_elderly_objectives_protocol_and_organization"},{"id":21351276,"url":"https://www.researchgate.net/publication/21351276_A_decade_of_progress_in_statistical_methodology_for_clinical_trials"},{"id":266430660,"url":"https://www.researchgate.net/publication/266430660_Two-Stage_Experimental_Designs_Early_Stopping_with_a_Negative_Result"},{"id":21826882,"url":"https://www.researchgate.net/publication/21826882_Study_duration_for_group_sequential_clinical_trials_with_censored_survival_data_adjusting_for_stratification"},{"id":240225881,"url":"https://www.researchgate.net/publication/240225881_Sample_size_re-estimation_without_unblinding_for_normally_distributed_data_with_unknown_variance"},{"id":227979155,"url":"https://www.researchgate.net/publication/227979155_Monitoring_clinical_trials_with_a_conditional_probability_stopping_rule"},{"id":227829175,"url":"https://www.researchgate.net/publication/227829175_A_decision-theoretic_evaluation_of_early_stopping_rules"},{"id":21370130,"url":"https://www.researchgate.net/publication/21370130_Exact_Statistical_Inference_for_Group_Sequential_Trials"},{"id":21597304,"url":"https://www.researchgate.net/publication/21597304_Interim_analyses_for_monitoring_clinical_trials_that_do_not_affect_the_Type_I_error_rate"},{"id":21636721,"url":"https://www.researchgate.net/publication/21636721_Sample_size_determination_for_group_sequential_clinical_trials_with_immediate_response"},{"id":283310089,"url":"https://www.researchgate.net/publication/283310089_Bootstrap_Tests_and_Confidence_Intervals_for_a_Hazard_Ratio_When_the_Number_of_Observed_Failures_is_Small_With_Applications_to_Group_Sequential_Survival_Studies"},{"id":254287031,"url":"https://www.researchgate.net/publication/254287031_Sequential_Rank_Tests_with_Repeated_Measurements_in_Clinical_Trials"},{"id":265589113,"url":"https://www.researchgate.net/publication/265589113_Sequential_Rank_Tests_With_Repeated_Measurements_in_Clinical_Trials"},{"id":21573223,"url":"https://www.researchgate.net/publication/21573223_The_Impact_of_Stopping_Rules_on_Heterogeneity_of_Results_in_Overviews_of_Clinical_Trials"},{"id":21838536,"url":"https://www.researchgate.net/publication/21838536_A_sequential_procedure_for_a_phase_II_efficacy_trial_in_hypercholesteremia"},{"id":21838535,"url":"https://www.researchgate.net/publication/21838535_Overrunning_and_underruning_in_sequential_clinical_trials"},{"id":21517701,"url":"https://www.researchgate.net/publication/21517701_A_New_Procedure_for_Group_Sequential_Analysis_in_Clinical_Trials"},{"id":21539279,"url":"https://www.researchgate.net/publication/21539279_Yu_YL_Kumana_CR_Lauder_IJ_Cheung_YK_Chan_FL_Kou_M_Chang_CM_Cheung_RT_Fong_KYTreatment_of_acute_cerebral_hemorrhage_with_intravenous_glycerol_A_double-blind_placebo-controlled_randomized_trial_Stroke_2"},{"id":21734555,"url":"https://www.researchgate.net/publication/21734555_Sequential_Monitoring_for_Comparison_of_Changes_in_a_Response_Variable_in_Clinical_Studies"},{"id":273097003,"url":"https://www.researchgate.net/publication/273097003_Effects_of_Assumption_Violations_on_Type_I_Error_Rate_in_Group_Sequential_Monitoring"},{"id":256422364,"url":"https://www.researchgate.net/publication/256422364_Bayesian_Approaches_for_Monitoring_Clinical_Trials_with_an_Application_to_Toxoplastic_Encephalitis_Prophylaxis"},{"id":21864501,"url":"https://www.researchgate.net/publication/21864501_Group_Sequential_Distribution-Free_Methods_for_the_Analysis_of_Multivariate_Observations"},{"id":232427633,"url":"https://www.researchgate.net/publication/232427633_Protective_Effect_of_Triflusal_against_Acute_Myocardial_Infarction_in_Patients_with_Unstable_Angina_Results_of_a_Spanish_Multicenter_Trial"},{"id":227698603,"url":"https://www.researchgate.net/publication/227698603_The_succession_procedure_for_interim_analysis_Extensions_for_early_acceptance_of_h0_and_for_flexible_times_of_analysis"},{"id":4853168,"url":"https://www.researchgate.net/publication/4853168_The_VPRT_A_sequential_testing_procedure_dominating_the_SPRT"},{"id":227756134,"url":"https://www.researchgate.net/publication/227756134_Interim_analyses_stopping_rules_and_data_monitoring_in_clinical_trials_in_Europe"},{"id":14706742,"url":"https://www.researchgate.net/publication/14706742_Monitoring_of_clinical_trials_and_interim_analyses_from_a_drug_Sponsor's_point_of_view"},{"id":14759402,"url":"https://www.researchgate.net/publication/14759402_Exact_repeated_confidence_intervals_for_Bernoulli_parameters_in_a_group_sequential_clinical_trial"},{"id":14712849,"url":"https://www.researchgate.net/publication/14712849_A_simple_stopping_rule_for_declaring_treatment_ineffectiveness_in_clinical_trials"},{"id":222490728,"url":"https://www.researchgate.net/publication/222490728_Application_of_a_sequential_t-test_in_a_cohort_nested_case-control_study_with_multiple_controls_per_case"},{"id":14688762,"url":"https://www.researchgate.net/publication/14688762_P-values_after_repeated_significance_testing_A_simple_approximation_method"},{"id":227660556,"url":"https://www.researchgate.net/publication/227660556_Sequential_monitoring_of_clinical_trials_The_role_of_information_and_Brownian_motion"},{"id":14699617,"url":"https://www.researchgate.net/publication/14699617_Computer_program_for_designing_clinical_trials_with_arbitrary_survival_curves_and_group_sequential_testing"},{"id":14860847,"url":"https://www.researchgate.net/publication/14860847_Stopping_guidelines_for_clinical_trials_multiple_treatments"},{"id":254086508,"url":"https://www.researchgate.net/publication/254086508_Sample_Size_Reestimation_for_Triple_Blind_Clinical_Trials"},{"id":254086506,"url":"https://www.researchgate.net/publication/254086506_The_Use_of_Interim_Analysis_for_Sample_Size_Adjustment"},{"id":14858850,"url":"https://www.researchgate.net/publication/14858850_Monitoring_of_clinical_trials_Issues_and_recommendations"},{"id":266610500,"url":"https://www.researchgate.net/publication/266610500_Optimal_Second-Order_Product_Probability_Bounds"},{"id":14958662,"url":"https://www.researchgate.net/publication/14958662_Optimization_of_Multistage_Testing_Times_and_Critical_Values_in_Clinical_Trials"},{"id":14958660,"url":"https://www.researchgate.net/publication/14958660_Group_Sequential_Tests_for_Bivariate_Response_Interim_Analyses_of_Clinical_Trials_with_Both_Efficacy_and_Safety_Endpoints"},{"id":14836426,"url":"https://www.researchgate.net/publication/14836426_An_introduction_to_the_use_of_interim_date_analysis_in_clinical_trials"},{"id":14889491,"url":"https://www.researchgate.net/publication/14889491_Use_of_spending_functions_for_occasional_or_continuous_monitoring_of_data_in_clinical_trials"},{"id":14956786,"url":"https://www.researchgate.net/publication/14956786_Effect_of_all-trans-retinoic_acid_in_newly_diagnosed_acute_promyelocytic_leukemia_Result_of_a_multicenter_randomized_trial_European_APL_91_Group"},{"id":243049806,"url":"https://www.researchgate.net/publication/243049806_Information_and_information_fractions_for_design_and_sequential_monitoring_of_clinical_trials"},{"id":239427832,"url":"https://www.researchgate.net/publication/239427832_Multistage_decission_problems"},{"id":233461374,"url":"https://www.researchgate.net/publication/233461374_A_two-stage_sequential_design_and_analysis_for_comparing_binomial_rates_with_possibly_random_dropouts"},{"id":229697959,"url":"https://www.researchgate.net/publication/229697959_Multiple_Testing_for_Detecting_Efficient_Dose_Steps"},{"id":233285672,"url":"https://www.researchgate.net/publication/233285672_Group_sequential_analysis_op_a_clinical_trial_with_repeated_measurements"},{"id":243049913,"url":"https://www.researchgate.net/publication/243049913_Three-stage_designs_for_monitoring_clinical_trials"},{"id":243048432,"url":"https://www.researchgate.net/publication/243048432_Approximations_in_a_group_sequential_test_with_unequal_group_sizes"},{"id":243049809,"url":"https://www.researchgate.net/publication/243049809_Use_of_the_randomization_distribution_in_the_analysis_of_sequential_clinical_trials"},{"id":14939662,"url":"https://www.researchgate.net/publication/14939662_A_simulated_sequential_analysis_based_on_data_from_two_MRC_trials"},{"id":14939663,"url":"https://www.researchgate.net/publication/14939663_Interim_analyses_and_stopping_rules_in_cancer_clinical_trials"},{"id":230265372,"url":"https://www.researchgate.net/publication/230265372_A_Group_Sequential_Method_for_one_Standard_Control_and_more_than_one_Experimental_Treatment"},{"id":243768179,"url":"https://www.researchgate.net/publication/243768179_Bayesian_Approaches_to_Randomized_Trials"},{"id":14968823,"url":"https://www.researchgate.net/publication/14968823_Effect_of_early_intravenous_lipid_administration_on_the_incidence_and_severity_of_chronic_lung_disease_in_premature_infants"},{"id":40207585,"url":"https://www.researchgate.net/publication/40207585_Efficient_use_of_biological_banks_for_biochemical_epidemiology_exploratory_hypothesis_testing_by_means_of_a_sequential_t-test"},{"id":251409115,"url":"https://www.researchgate.net/publication/251409115_Multicenter_Trials_Design_and_Conduct"},{"id":15077300,"url":"https://www.researchgate.net/publication/15077300_Group_sequential_testing_in_clinical_trials_with_multivariate_observations_A_review"},{"id":15111856,"url":"https://www.researchgate.net/publication/15111856_The_Performance_of_the_O'Brien-Fleming_Multiple_Testing_Procedure_in_the_Presence_of_Intraclass_Correlation"},{"id":15110755,"url":"https://www.researchgate.net/publication/15110755_Early_stopping_rules_and_long-term_follow-up_in_Phase_III_trials"},{"id":15150994,"url":"https://www.researchgate.net/publication/15150994_Use_of_surrogate_information_time_for_monitoring_the_effect_of_treatment_on_the_change_in_a_response_variable_in_clinical_trials"},{"id":254086589,"url":"https://www.researchgate.net/publication/254086589_Sample_Size_Estimation_When_Time-to-Event_is_the_Primary_Endpoint"},{"id":15248511,"url":"https://www.researchgate.net/publication/15248511_Multistage_test_procedure_for_testing_Blackwelder's_hypothesis_of_equivalence"},{"id":15130082,"url":"https://www.researchgate.net/publication/15130082_Monitoring_Pairwise_Comparisons_in_Multi-Armed_Clinical_Trials"},{"id":15226460,"url":"https://www.researchgate.net/publication/15226460_The_case_against_independent_monitoring_committees"},{"id":15226456,"url":"https://www.researchgate.net/publication/15226456_Sequential_methods_based_on_boundaries_approach_for_the_clinical_comparison_of_survival_times"},{"id":227934758,"url":"https://www.researchgate.net/publication/227934758_Interim_analysis_The_alpha_spending_approach"},{"id":227779222,"url":"https://www.researchgate.net/publication/227779222_Monitoring_multi-armed_trials"},{"id":230175089,"url":"https://www.researchgate.net/publication/230175089_Discussion_of_'interim_analysis_The_alpha_spending_approach'"},{"id":15280046,"url":"https://www.researchgate.net/publication/15280046_Efficient_use_of_biological_banks_for_biochemical_epidemiology_exploratory_hypothesis_testing_by_means_of_a_sequential_t-test"},{"id":239481414,"url":"https://www.researchgate.net/publication/239481414_Randomised_trial_of_low-dose_amiodarone_in_severe_congestive_heart_failure"},{"id":15395152,"url":"https://www.researchgate.net/publication/15395152_The_Hypertension_in_the_Very_Elderly_Trial_HYVET_Rationale_methodology_and_comparison_with_previous_trials"},{"id":227960060,"url":"https://www.researchgate.net/publication/227960060_A_unified_method_for_monitoring_and_analysing_controlled_trials"},{"id":15218637,"url":"https://www.researchgate.net/publication/15218637_A_Sample-Size-Optimal_Bayesian_Procedure_for_Sequential_Pharmaceutical_Trials"},{"id":15468094,"url":"https://www.researchgate.net/publication/15468094_Data_monitoring_in_clinical_trials_The_case_for_stochastic_curtailment"},{"id":223223758,"url":"https://www.researchgate.net/publication/223223758_Data_monitoring_in_complex_clinical_trials_Which_treatment_is_better"},{"id":15342692,"url":"https://www.researchgate.net/publication/15342692_Monitoring_of_a_pilot_toxicity_study_with_two_adverse_outcomes"},{"id":254287635,"url":"https://www.researchgate.net/publication/254287635_Group_Sequential_Clinical_Trials_A_Classical_Evaluation_of_Bayesian_Decision-Theoretic_Designs"},{"id":15220807,"url":"https://www.researchgate.net/publication/15220807_Comments_on_randomized_controlled_trial_of_epidural_analgesia_in_labor"},{"id":230173474,"url":"https://www.researchgate.net/publication/230173474_Two-stage_sampling_for_bounding_a_mean"},{"id":245495786,"url":"https://www.researchgate.net/publication/245495786_Optimal_two-sided_group_sequential_tests"},{"id":15412184,"url":"https://www.researchgate.net/publication/15412184_Exact_Permutational_Tests_for_Group_Sequential_Clinical_Trials"},{"id":15412193,"url":"https://www.researchgate.net/publication/15412193_Guidelines_for_Monitoring_Efficacy_and_Toxicity_Responses_in_Clinical_Trials"},{"id":243042900,"url":"https://www.researchgate.net/publication/243042900_Sequential_testing_with_interval_censored_data"},{"id":15559313,"url":"https://www.researchgate.net/publication/15559313_The_alpha_spending_function_approach_to_interim_data_analyses"},{"id":227894220,"url":"https://www.researchgate.net/publication/227894220_A_Bayesian_group_sequential_design_for_a_multiple_arm_randomized_clinical_trial"},{"id":15401790,"url":"https://www.researchgate.net/publication/15401790_SEQPWR_and_SEQOPR_computer_programs_for_design_of_maximum_information_trials_based_on_group_sequential_logrank_tests"},{"id":254087017,"url":"https://www.researchgate.net/publication/254087017_Group_Sequential_Monitoring_of_Multi-Armed_Clinical_Trials"},{"id":15431968,"url":"https://www.researchgate.net/publication/15431968_Group_Sequential_Comparison_of_Changes_Ad-hoc_Versus_More_Exact_Method"},{"id":15536010,"url":"https://www.researchgate.net/publication/15536010_Bivariate_Sequential_Designs_for_Phase_II_Trials"},{"id":31186052,"url":"https://www.researchgate.net/publication/31186052_P-values_for_group_sequential_testing"},{"id":258131654,"url":"https://www.researchgate.net/publication/258131654_Group_Sequential_Monitoring_of_Clinical_Trials_with_Multivariate_Outcomes"},{"id":15649818,"url":"https://www.researchgate.net/publication/15649818_Sequential_Monitoring_of_Survival_Data_with_the_Wilcoxon_Statistic"},{"id":15649826,"url":"https://www.researchgate.net/publication/15649826_Interim_Analyses_in_2_x_2_Crossover_Trials"},{"id":15649827,"url":"https://www.researchgate.net/publication/15649827_A_Group_Sequential_Procedure_for_All-Pairwise_Comparisons_of_k_Treatments_Based_on_the_Range_Statistic"},{"id":15649816,"url":"https://www.researchgate.net/publication/15649816_Stopping_a_Clinical_Trial_Very_Early_Based_on_Unplanned_Interim_Analyses_A_Group_Sequential_Approach"},{"id":15649831,"url":"https://www.researchgate.net/publication/15649831_Design_and_Analysis_of_Group_Sequential_Logrank_Tests_in_Maximum_Duration_Versus_Information_Trials"},{"id":222253825,"url":"https://www.researchgate.net/publication/222253825_The_Data_and_Safety_Monitoring_Board_and_Acquired_Immune_Deficiency_Syndrome_AIDS_Clinical_Trials"},{"id":233212557,"url":"https://www.researchgate.net/publication/233212557_Sequential_type_nonparametric_tests_for_ordered_bivariate_alterenatives"},{"id":254362113,"url":"https://www.researchgate.net/publication/254362113_Efficient_allocations_in_group_sequential_tests"},{"id":14225803,"url":"https://www.researchgate.net/publication/14225803_Comparison_of_one-sample_two-sided_sequential_t-tests_for_application_in_epidemiological_studies"},{"id":233122103,"url":"https://www.researchgate.net/publication/233122103_Optimal_designs_for_group_sequential_clinical_trials"},{"id":270254654,"url":"https://www.researchgate.net/publication/270254654_Multiplicity_Considerations_in_the_Design_and_Analysis_of_Clinical_Trials"},{"id":264946126,"url":"https://www.researchgate.net/publication/264946126_Sequential_monitoring_of_clinical_trials_with_correlated_responses"},{"id":14578891,"url":"https://www.researchgate.net/publication/14578891_A_Randomised_Controlled_Trial_of_Vitamin_E_in_Patients_with_Coronary_Disease_The_Cambridge_Heart_Antioxidant_Study_CHAOS"},{"id":254331041,"url":"https://www.researchgate.net/publication/254331041_Statistical_Packages_for_Group_Sequential_Methods"},{"id":14528441,"url":"https://www.researchgate.net/publication/14528441_Coupled_Error_Spending_Functions_for_Parallel_Bivariate_Sequential_Tests"},{"id":14528452,"url":"https://www.researchgate.net/publication/14528452_Design_Considerations_in_Crossover_Trials_with_a_Single_Interim_Analysis_and_Serial_Patient_Entry"},{"id":14398600,"url":"https://www.researchgate.net/publication/14398600_Group_Sequential_Designs_for_Monitoring_Survival_Probabilities"},{"id":254086874,"url":"https://www.researchgate.net/publication/254086874_A_Step-by-Step_Recommendation_for_Sample_Size_Adjustment_in_Clinical_Trials"},{"id":14276377,"url":"https://www.researchgate.net/publication/14276377_Sequential_monitoring_of_clinical_trials_with_multiple_survival_endpoints"},{"id":14201660,"url":"https://www.researchgate.net/publication/14201660_Selegiline_and_mortality_in_Parkinson's_disease"},{"id":250755042,"url":"https://www.researchgate.net/publication/250755042_1_The_design_and_analysis_of_clinical_trials"},{"id":243050039,"url":"https://www.researchgate.net/publication/243050039_Application_of_boundary_calculation_methodologies_to_group_sequential_testing_in_general_parametric_models"},{"id":243049943,"url":"https://www.researchgate.net/publication/243049943_Group_sequential_x_statistic_for_testing_the_difference_of_two_mean_vectors_in_clinical_trials"},{"id":14234092,"url":"https://www.researchgate.net/publication/14234092_Data_monitoring_committees_and_problems_of_lower-than-expected_accrual_or_event_rates"},{"id":233300452,"url":"https://www.researchgate.net/publication/233300452_Generalization_of_a_lemma_of_kiefer_and_weiss_for_the_case_of_sequentially_planned_decision_problems_with_more_than_two_hypotheses"},{"id":233221372,"url":"https://www.researchgate.net/publication/233221372_Incorporation_of_a_stopping_criterion_for_futility_into_the_design_of_a_clinical_trial_with_one_interim_analysis"},{"id":14246218,"url":"https://www.researchgate.net/publication/14246218_Interim_Monitoring_of_Longitudinal_Comparative_Studies_with_Recurrent_Event_Responses"},{"id":14246222,"url":"https://www.researchgate.net/publication/14246222_Designs_for_Phase_II_Trials_Allowing_for_a_Trade-Off_between_Response_and_Toxicity"},{"id":31327024,"url":"https://www.researchgate.net/publication/31327024_The_length_heuristic_for_simultaneous_hypothesis_tests"},{"id":31327029,"url":"https://www.researchgate.net/publication/31327029_Conditional_power_with_Fisher's_least_significant_difference_procedure"},{"id":14131703,"url":"https://www.researchgate.net/publication/14131703_The_triangular_test_to_assess_the_efficacy_of_metoclopramide_in_gastroesophageal_reflux"},{"id":14154176,"url":"https://www.researchgate.net/publication/14154176_A_group_sequential_approach_to_crossover_trials_for_average_bioequivalence"},{"id":246373103,"url":"https://www.researchgate.net/publication/246373103_15_Optimization_of_testing_times_and_critical_values_in_sequential_equivalence_testing"},{"id":238331303,"url":"https://www.researchgate.net/publication/238331303_A_randomised_clinical_trial_comparing_interferon-_and_intravenous_gammaglobulin_in_polyneuropathy_associated_with_monoclonal_IgM"},{"id":13966979,"url":"https://www.researchgate.net/publication/13966979_A_sequential_trial_of_pain_killers_in_arthritis_Issues_of_multiple_comparisons_with_control_and_of_interval-censored_data"},{"id":13931393,"url":"https://www.researchgate.net/publication/13931393_Early_Stopping_to_Accept_H_0_Based_on_Conditional_Power_Approximations_and_Comparisons"},{"id":13894603,"url":"https://www.researchgate.net/publication/13894603_Sequential_Analysis_of_Censored_Survival_Data_From_Three_Treatment_Groups"},{"id":31062341,"url":"https://www.researchgate.net/publication/31062341_Estimating_bias_in_group_sequential_designs_with_Gaussian_independent_increment_structure"},{"id":227822538,"url":"https://www.researchgate.net/publication/227822538_Optimal_three-stage_designs_for_phase_II_cancer_clinical_trials"},{"id":13820965,"url":"https://www.researchgate.net/publication/13820965_Cumulating_evidence_from_randomized_trials_utilizing_sequential_monitoring_boundaries_for_cumulative_meta-Analysis"},{"id":243050215,"url":"https://www.researchgate.net/publication/243050215_Group_sequential_designs_using_both_type_I_and_type_II_error_probability_spending_function"},{"id":243050204,"url":"https://www.researchgate.net/publication/243050204_Repeated_significance_tests_on_accumulating_data_of_repairable_systems"},{"id":251404276,"url":"https://www.researchgate.net/publication/251404276_Nonparametric_Bayesian_Group_Sequential_Design"},{"id":13239325,"url":"https://www.researchgate.net/publication/13239325_Interim_Analyses_of_Survival_Data_in_Cancer_Clinical_Trials"},{"id":13766721,"url":"https://www.researchgate.net/publication/13766721_The_Use_of_Simulation_and_Bootstrap_in_Information-Based_Group_Sequential_Studies"},{"id":227114454,"url":"https://www.researchgate.net/publication/227114454_Sequential_Designs_in_Clinical_Trials"},{"id":13734214,"url":"https://www.researchgate.net/publication/13734214_HIV-1_RNA_endpoints_in_HIV_clinical_trials_Issues_in_interim_monitoring_and_early_stopping"},{"id":13689950,"url":"https://www.researchgate.net/publication/13689950_Chlorambucil_in_Indolent_Chronic_Lymphocytic_Leukemia"},{"id":13654222,"url":"https://www.researchgate.net/publication/13654222_A_Comparison_of_Two_Methods_for_Adaptive_Interim_Analyses_in_Clinical_Trials"},{"id":13654221,"url":"https://www.researchgate.net/publication/13654221_Clinical_Trial_Designs_Based_on_Sequential_Conditional_Probability_Ratio_Tests_and_Reverse_Stochastic_Curtailing"},{"id":13586502,"url":"https://www.researchgate.net/publication/13586502_Self-designing_clinical_trials"},{"id":13536177,"url":"https://www.researchgate.net/publication/13536177_Construction_of_a_Continuous_Stopping_Boundary_from_an_Alpha_Spending_Function"},{"id":13466527,"url":"https://www.researchgate.net/publication/13466527_Chen_TT_Ng_THOptimal_flexible_designs_in_phase_II_clinical_trials_Stat_Med_17_2301-2312"},{"id":225493919,"url":"https://www.researchgate.net/publication/225493919_A_better_stopping_rule_for_conventional_statistical_tests"},{"id":224773241,"url":"https://www.researchgate.net/publication/224773241_Interim_Analyses_An_FDA_Reviewer's_Experience_and_Perspective"},{"id":233106727,"url":"https://www.researchgate.net/publication/233106727_Group_sequential_checking_of_the_proportional_hazards_assumption_based_on_a_time-dependent_covariate"},{"id":246832899,"url":"https://www.researchgate.net/publication/246832899_Monitoring_of_clinical_trials_Establishment_measures_and_consequences_Begrundungen_Massnahmen_und_Konsequenzen"},{"id":13084364,"url":"https://www.researchgate.net/publication/13084364_Assessing_Effects_on_Long-term_Survival_after_Early_Termination_of_Randomized_Trials"},{"id":23633655,"url":"https://www.researchgate.net/publication/23633655_A_one-sided_confidence_set_hidden_under_a_two-sided_sequential_test_of_a_normal_mean"},{"id":4893986,"url":"https://www.researchgate.net/publication/4893986_Estimation_following_group_sequential_tests_with_repeated_measurements_data"},{"id":264334473,"url":"https://www.researchgate.net/publication/264334473_A_Group_Sequential_Test_for_Survival_Trials_An_Alternative_to_Rank-Based_Procedures"},{"id":254087373,"url":"https://www.researchgate.net/publication/254087373_Sequential_Designs_for_Monitoring_Two_Endpoints_in_a_Clinical_Trial"},{"id":12018075,"url":"https://www.researchgate.net/publication/12018075_Statistical_Inference_for_Self-Designing_Clinical_Trials_with_a_One-Sided_Hypothesis"},{"id":242939902,"url":"https://www.researchgate.net/publication/242939902_Group_Sequential_Monitoring_with_Arbitrary_Inspection_Times"},{"id":12967823,"url":"https://www.researchgate.net/publication/12967823_Berman_R_M_et_al_The_use_of_pindolol_with_fluoxetine_in_the_treatment_of_major_depression_final_results_from_a_double-blind_placebo-controlled_trial_Biol_Psychiatry_45_1170-1177"},{"id":254287690,"url":"https://www.researchgate.net/publication/254287690_A_General_Theory_on_Stochastic_Curtailment_for_Censored_Survival_Data"},{"id":238874688,"url":"https://www.researchgate.net/publication/238874688_Miscellanea_Properties_of_spending_function_boundaries"},{"id":227816783,"url":"https://www.researchgate.net/publication/227816783_Inference_on_Multiple_Endpoints_in_Clinical_Trials_with_Adaptive_Interim_Analyses"},{"id":12892643,"url":"https://www.researchgate.net/publication/12892643_Albert_PS_Longitudinal_data_analysis_repeated_measures_in_clinical_trials"},{"id":12900506,"url":"https://www.researchgate.net/publication/12900506_Interim_analyses_with_delayed_observations_in_clinical_trials"},{"id":12892651,"url":"https://www.researchgate.net/publication/12892651_Optimization_of_testing_times_and_critical_values_in_sequential_equivalence_testing"},{"id":12827067,"url":"https://www.researchgate.net/publication/12827067_Group_sequential_procedures_for_repeated_events_data_with_frailty"},{"id":30967975,"url":"https://www.researchgate.net/publication/30967975_Interim_analyses_using_repeated_confidence_bands"},{"id":12826186,"url":"https://www.researchgate.net/publication/12826186_Group_sequential_analyses_for_the_mean_function_of_a_repeated_measure_process"},{"id":12019863,"url":"https://www.researchgate.net/publication/12019863_Modification_of_Sample_Size_in_Group_Sequential_Clinical_Trials"},{"id":12019866,"url":"https://www.researchgate.net/publication/12019866_A_Unifying_Family_of_Group_Sequential_Test_Designs"},{"id":12796256,"url":"https://www.researchgate.net/publication/12796256_Data_Monitoring_Committees_and_Interim_Monitoring_Guidelines"},{"id":12796258,"url":"https://www.researchgate.net/publication/12796258_Determination_of_Power_and_Sample_Size_in_the_Design_of_Clinical_Trials_with_Failure-Time_Endpoints_and_Interim_Analyses"},{"id":12725652,"url":"https://www.researchgate.net/publication/12725652_Statistical_Methods_for_monitoring_clinical_trials"},{"id":223366774,"url":"https://www.researchgate.net/publication/223366774_Procedures_for_testing_multiple_endpoints_in_clinical_trials_An_overview"},{"id":12773610,"url":"https://www.researchgate.net/publication/12773610_Repeated_Significance_Tests_on_Accumulating_Survival_Data"},{"id":12019931,"url":"https://www.researchgate.net/publication/12019931_Adaptive_Sample_Size_Calculations_in_Group_Sequential_Trials"},{"id":12692598,"url":"https://www.researchgate.net/publication/12692598_The_agonizing_negative_trend_in_monitoring_clinical_trials"},{"id":233470835,"url":"https://www.researchgate.net/publication/233470835_Optimal_two-stage_designs_for_phase_II_trials_with_differentiation_of_complete_and_partial_responses"},{"id":233155460,"url":"https://www.researchgate.net/publication/233155460_Procedure_for_determining_sample_size_at_each_stage_in_group_sequential_test"},{"id":224839812,"url":"https://www.researchgate.net/publication/224839812_SSeqTrial_Technical_Overview"},{"id":228608363,"url":"https://www.researchgate.net/publication/228608363_Hybrid_resampling_methods_for_confidence_intervals"},{"id":277421532,"url":"https://www.researchgate.net/publication/277421532_Somatostatin_plus_isosorbide_5-mononitrate_versus_somatostatin_in_the_control_of_acute_gastro-oesophageal_variceal_bleeding_a_double_blind_randomised_placebo_controlled_clinical_trial"},{"id":12586418,"url":"https://www.researchgate.net/publication/12586418_Individually_randomized_intervention_trials_for_disease_prevention_and_control"},{"id":12700484,"url":"https://www.researchgate.net/publication/12700484_Somatostatin_plus_isosorbide_5-mononitrate_versus_somatostatin_in_the_control_of_acute_gastro-oesophageal_variceal_bleeding_a_double_blind_randomised_placebo_controlled_clinical_trial"},{"id":12673527,"url":"https://www.researchgate.net/publication/12673527_Sample_size_calculation_for_planning_group_sequential_longitudinal_trials"},{"id":12694447,"url":"https://www.researchgate.net/publication/12694447_A_trial_of_thyroxine_in_acute_renal_failure"},{"id":254331224,"url":"https://www.researchgate.net/publication/254331224_Alternative_Derivations_of_a_Rule_for_Early_Stopping_in_Favor_of_H0"},{"id":262950347,"url":"https://www.researchgate.net/publication/262950347_A_Homogeneity_Test_in_Overviews_with_Group_Sequentially_Monitored_Clinical_Trials"},{"id":254288075,"url":"https://www.researchgate.net/publication/254288075_Some_Contributions_of_Statistics_to_Environmental_Epidemiology"},{"id":261741993,"url":"https://www.researchgate.net/publication/261741993_The_Randomized_Clinical_Trial"},{"id":31303346,"url":"https://www.researchgate.net/publication/31303346_A_Group_Sequential_T-test_With_Updating_of_Sample_Size"},{"id":239771450,"url":"https://www.researchgate.net/publication/239771450_Operational_Difficulties_with_Internal_Pilot_Studies_to_Update_Sample_Size"},{"id":12464448,"url":"https://www.researchgate.net/publication/12464448_The_problem_of_performing_adequately_sized_randomized_trials_to_demonstrate_small_survival_benefits"},{"id":12536149,"url":"https://www.researchgate.net/publication/12536149_Comparison_of_four_sequential_methods_allowing_for_early_stopping_of_comparative_clinical_trials"},{"id":2641870,"url":"https://www.researchgate.net/publication/2641870_On_Group_Sequential_Tests_Based_on_Robust_Location_and_Scale_Estimators_in_the_Two-Sample_Problem"},{"id":225431527,"url":"https://www.researchgate.net/publication/225431527_Basic_concepts_of_group_sequential_and_adaptive_group_sequential_procedures"},{"id":12496174,"url":"https://www.researchgate.net/publication/12496174_Computations_for_Group_Sequential_Boundaries_Using_the_Lan-DeMets_Spending_Function_Method"},{"id":12442304,"url":"https://www.researchgate.net/publication/12442304_Testing_Secondary_Hypotheses_Following_Sequential_Clinical_Trials"},{"id":2471982,"url":"https://www.researchgate.net/publication/2471982_Survival_Analysis_in_Clinical_Trials_Past_Developments_and_Future_Directions"},{"id":12370655,"url":"https://www.researchgate.net/publication/12370655_Quality_control_of_oncology_clinical_trials"},{"id":12381239,"url":"https://www.researchgate.net/publication/12381239_Screening_endpoint_classification_and_safety_monitoring_in_the_Metoprolol_CRXL_Randomised_Intervention_Trial_in_Congestive_Heart_Failure_MERIT-HF"},{"id":12305942,"url":"https://www.researchgate.net/publication/12305942_A_Trial_of_Shortened_Zidovudine_Regimens_to_Prevent_Mother-to-Child_Transmission_of_Human_Immunodeficiency_Virus_Type_1"},{"id":240620592,"url":"https://www.researchgate.net/publication/240620592_18_Statistical_perspectives_in_clinical_epidemiology"},{"id":250755041,"url":"https://www.researchgate.net/publication/250755041_9_Non-parametrics_in_bioenvironmental_and_public_health_statistics"},{"id":12124916,"url":"https://www.researchgate.net/publication/12124916_Limitations_of_Randomized_Clinical_Trials_Proposed_Alternative_Designs"},{"id":12198435,"url":"https://www.researchgate.net/publication/12198435_Nonparametric_Rank-Based_Methods_for_Group_Sequential_Monitoring_of_Paired_Censored_Survival_Data"},{"id":12159921,"url":"https://www.researchgate.net/publication/12159921_Interim_monitoring_of_clinical_trials_based_on_long-term_binary_endpoints"},{"id":11585202,"url":"https://www.researchgate.net/publication/11585202_Taxanes_in_the_Adjuvant_Treatment_of_Breast_Cancer_Why_Not_Yet"},{"id":246374983,"url":"https://www.researchgate.net/publication/246374983_Group_Sequential_Methods_with_Applications_to_Clinical_Trials"},{"id":12165457,"url":"https://www.researchgate.net/publication/12165457_Operational_Aspects_of_Terminating_the_Doxazosin_Arm_of_the_Antihypertensive_and_Lipid_Lowering_Treatment_to_Prevent_Heart_Attack_Trial_ALLHAT"},{"id":31476147,"url":"https://www.researchgate.net/publication/31476147_One_hundred_years_of_the_design_of_experiments_on_and_off_the_pages_of_Biometrika"},{"id":228483048,"url":"https://www.researchgate.net/publication/228483048_Sequential_analysis_Some_classical_problems_and_new_challenges"},{"id":12057440,"url":"https://www.researchgate.net/publication/12057440_Optimal_two-stage_designs_for_clinical_trials_based_on_safety_and_efficacy"},{"id":2400475,"url":"https://www.researchgate.net/publication/2400475_Early_Detection_of_Reliability_Problems_Using_Information_From_Warranty_Databases"},{"id":11918463,"url":"https://www.researchgate.net/publication/11918463_Interim_analyses_in_phase_III_studies"},{"id":222650246,"url":"https://www.researchgate.net/publication/222650246_On_group_sequential_tests_for_data_in_unequally_sized_groups_and_with_unknown_variance"},{"id":11924808,"url":"https://www.researchgate.net/publication/11924808_Estimation_of_a_Secondary_Parameter_in_a_Group_Sequential_Clinical_Trial"},{"id":264257095,"url":"https://www.researchgate.net/publication/264257095_Probabilistic_Techniques_in_Exposure_Assessment_A_Handbook_for_Dealing_with_Variability_and_Uncertainty_in_Models_and_Inputs_A_C_Cullen_and_H_C_Frey_Plenum_Press_New_York_and_London_1999_No_of_pages_i"},{"id":239994474,"url":"https://www.researchgate.net/publication/239994474_Group_Sequential_Methods_with_Applications_to_Clinical_Trials_Christopher_Jennison_and_Bruce_W_Turnbull_CRCChapman_Hall_UK_2000_No_of_pages_xviii_390_Price_3900_ISBN_0-849-30316-8"},{"id":230004951,"url":"https://www.researchgate.net/publication/230004951_Sequential_Designs_for_Genetic_Epidemiological_Linkage_or_Association_Studies_A_Review_of_the_Literature"},{"id":227692218,"url":"https://www.researchgate.net/publication/227692218_A_Simple_Algorithm_for_Designing_Group_Sequential_Clinical_Trials"},{"id":227667837,"url":"https://www.researchgate.net/publication/227667837_Adaptive_Group_Sequential_Designs_for_Clinical_Trials_Combining_the_Advantages_of_Adaptive_and_of_Classical_Group_Sequential_Approaches"},{"id":224773238,"url":"https://www.researchgate.net/publication/224773238_Adaptive_Modifications_of_Hypotheses_After_an_Interim_Analysis"},{"id":11809989,"url":"https://www.researchgate.net/publication/11809989_Effect_of_raloxifene_on_breast_cancer_cell_Ki67_and_apoptosis_A_double-blind_placebo-controlled_randomized_clinical_trial_in_postmenopausal_patients"},{"id":227883573,"url":"https://www.researchgate.net/publication/227883573_Sample_size_re-estimation_Recent_developments_and_practical_considerations"},{"id":227960127,"url":"https://www.researchgate.net/publication/227960127_Theory_and_practice_in_medical_statistics"},{"id":11862791,"url":"https://www.researchgate.net/publication/11862791_Optimized_Group_Sequential_Study_Designs_for_Tests_of_Genetic_Linkage_and_Association_in_Complex_Diseases"},{"id":11769384,"url":"https://www.researchgate.net/publication/11769384_Comparison_of_the_Two-Sided_Single_Triangular_Test_to_the_Double_Triangular_Test"},{"id":254087420,"url":"https://www.researchgate.net/publication/254087420_Flexible_Interim_Analyses_in_Clinical_Trials_Using_Multistage_Adaptive_Test_Designs"},{"id":254087536,"url":"https://www.researchgate.net/publication/254087536_Sample_Size_Reestimation_in_Clinical_Trials"},{"id":246202957,"url":"https://www.researchgate.net/publication/246202957_Flexible_Sample_Size_Considerations_Using_Information-Based_Interim_Monitoring"},{"id":254087537,"url":"https://www.researchgate.net/publication/254087537_Clinical_Trials_with_an_Adaptive_Choice_of_Hypotheses"},{"id":11796497,"url":"https://www.researchgate.net/publication/11796497_Monitoring_Clinical_Trials_with_Multiple_Arms"},{"id":11631285,"url":"https://www.researchgate.net/publication/11631285_The_use_of_state_of_the_art_statistical_methodology_in_biomedical_research_the_example_of_methodology_for_interim_analyses_in_clinical_trials"},{"id":245496049,"url":"https://www.researchgate.net/publication/245496049_Group_sequential_tests_with_outcome-dependent_treatment_assignment"},{"id":11352584,"url":"https://www.researchgate.net/publication/11352584_A_case_study_of_the_effect_of_covariate_adjustment_in_a_sequential_survival_clinical_trial"},{"id":11352586,"url":"https://www.researchgate.net/publication/11352586_Sample_sizes_for_batch_acceptance_from_single-_and_multistage_designs_using_two-sided_normal_tolerance_intervals_with_specified_content"},{"id":11611275,"url":"https://www.researchgate.net/publication/11611275_Use_of_the_equivalence_approach_in_reproductive_health_clinical_trials"},{"id":4013157,"url":"https://www.researchgate.net/publication/4013157_A_novel_MEMS_gas_sensor_with_effective_combination_of_high_sensitivity_and_high_selectivity"},{"id":233164764,"url":"https://www.researchgate.net/publication/233164764_Confidence_Intervals_Following_Group_Sequential_Tests_in_Clinical_Trails_with_Multivariate_Observations"},{"id":232947166,"url":"https://www.researchgate.net/publication/232947166_REPEATED_SIGNIFICANCE_TESTS_IN_FREQUENCY_AND_TIME_DOMAINS"},{"id":11576252,"url":"https://www.researchgate.net/publication/11576252_Group_sequential_monitoring_of_years_of_life_saved_with_paired_censored_survival_data"},{"id":11258732,"url":"https://www.researchgate.net/publication/11258732_Sample_Size_Calculations_for_Randomized_Controlled_Trials"},{"id":11258731,"url":"https://www.researchgate.net/publication/11258731_Analysis_of_randomized_controlled_trials_Epidemiol_Rev"},{"id":3948042,"url":"https://www.researchgate.net/publication/3948042_Near_optimum_low_complexity_MMSE_multi-user_detector"},{"id":4745580,"url":"https://www.researchgate.net/publication/4745580_Recursive_Combination_Tests"},{"id":11485997,"url":"https://www.researchgate.net/publication/11485997_Avramis_V_I_et_al_A_randomized_comparison_of_native_Escherichia_coli_asparaginase_and_polyethylene_glycol_conjugated_asparaginase_for_treatment_of_children_with_newly_diagnosed_standard-risk_acute_lym"},{"id":243050135,"url":"https://www.researchgate.net/publication/243050135_Adaptive_group_sequential_procedures_for_multiple_comparison_of_treatments"},{"id":11292887,"url":"https://www.researchgate.net/publication/11292887_Challenges_associated_with_the_evaluation_of_veterinary_product_bioequivalence_An_AAVPT_perspective"},{"id":11304161,"url":"https://www.researchgate.net/publication/11304161_Self-Designing_Two-Stage_Trials_to_Minimize_Expected_Costs"},{"id":274446471,"url":"https://www.researchgate.net/publication/274446471_Analysis_of_Randomized_Controlled_Trials"},{"id":11266479,"url":"https://www.researchgate.net/publication/11266479_Designing_complex_group_sequential_survival_trials"},{"id":11210145,"url":"https://www.researchgate.net/publication/11210145_Canadian_Bone_Marrow_Transplant_Group_A_randomized_multicenter_comparison_of_bone_marrow_and_peripheral_blood_in_recipients_of_matched_sibling_allogeneic_transplants_for_myeloid_malignancies"},{"id":11182476,"url":"https://www.researchgate.net/publication/11182476_Minimax_two-stage-designs_with_applications_to_tissue_banking_case-control_studies"},{"id":11159969,"url":"https://www.researchgate.net/publication/11159969_Group_Sequential_Methods_for_an_Ordinal_Logistic_Random-Effects_Model_Under_Misspecification"},{"id":11075506,"url":"https://www.researchgate.net/publication/11075506_Effect_of_general_hospital_management_on_repeat_episodes_of_deliberate_self_poisoning_Cohort_study"},{"id":11099144,"url":"https://www.researchgate.net/publication/11099144_Ethics_data-dependent_designs_and_the_strategy_of_clinical_trials_Time_to_start_learning-as-we-go"},{"id":4013828,"url":"https://www.researchgate.net/publication/4013828_Algorithmic_and_implementation_aspects_of_echo_cancellation_in_packet_voice_networks"},{"id":10979810,"url":"https://www.researchgate.net/publication/10979810_P-Value_Adjustment_in_Sequential_Clinical_Trials"},{"id":229785244,"url":"https://www.researchgate.net/publication/229785244_Conditional_Inference_Following_Group_Sequential_Testing"},{"id":227923406,"url":"https://www.researchgate.net/publication/227923406_A_New_Class_of_Completely_Self-Designing_Clinical_Trials"},{"id":243044620,"url":"https://www.researchgate.net/publication/243044620_An_Efficient_Allocation_in_Group_Sequential_Tests_for_the_Linear_Mixed_Effects_Model"},{"id":9012312,"url":"https://www.researchgate.net/publication/9012312_Group_Sequential_Study_Designs_in_Genetic-Epidemiological_Case-Control_Studies"},{"id":4746462,"url":"https://www.researchgate.net/publication/4746462_Sample_Size_Reestimation_for_Clinical_Trials_With_Censored_Survival_Data"},{"id":9012311,"url":"https://www.researchgate.net/publication/9012311_Data_Adaptive_Interim_Modification_of_Sample_Sizes_for_Candidate-Gene_Association_Studies"},{"id":10897829,"url":"https://www.researchgate.net/publication/10897829_A_comparison_of_group_sequential_methods_for_binary_longitudinal_data"},{"id":8444449,"url":"https://www.researchgate.net/publication/8444449_Somlyo_A_V_et_al_Rho_kinase_and_matrix_metalloproteinase_inhibitors_cooperate_to_inhibit_angiogenesis_and_growth_of_human_prostate_cancer_xenotransplants_FASEB_J_17_223-234"},{"id":10896452,"url":"https://www.researchgate.net/publication/10896452_Indexed_Families_of_Functionals_and_Gaussian_Radial_Basis_Functions"},{"id":10923527,"url":"https://www.researchgate.net/publication/10923527_Monitoring_mortality_at_interim_analyses_while_testing_a_composite_endpoint_at_the_final_analysis"},{"id":10861519,"url":"https://www.researchgate.net/publication/10861519_Planning_and_monitoring_of_placebo-controlled_survival_trials_Comparison_of_the_triangular_test_with_usual_interim_analyses_methods"},{"id":8220901,"url":"https://www.researchgate.net/publication/8220901_Group_sequential_design_for_diagnostic_accuracy_studies"},{"id":10865383,"url":"https://www.researchgate.net/publication/10865383_Issues_in_Designing_Flexible_Trials"},{"id":7176153,"url":"https://www.researchgate.net/publication/7176153_Sequential_Tests_for_Noninferiority_and_Superiority"},{"id":229448800,"url":"https://www.researchgate.net/publication/229448800_Improved_Repeated_Confidence_Bounds_in_Trials_with_a_Maximal_Goal"},{"id":38348878,"url":"https://www.researchgate.net/publication/38348878_Herbert_Robbins_and_sequential_analysis"},{"id":10843654,"url":"https://www.researchgate.net/publication/10843654_Single_nucleotide_polymorphism_-_Disease_relationships_Statistical_issues_for_the_performance_of_association_studies"},{"id":10783131,"url":"https://www.researchgate.net/publication/10783131_Sequential_classification_in_glaucoma_diagnosis"},{"id":246175843,"url":"https://www.researchgate.net/publication/246175843_Outpatient_cognitive_behavioral_pain_management_programs_a_randomized_comparison_of_a_group-based_multidisciplinary_versus_an_individual_therapy_model_1_1_No_commercial_party_having_a_direct_financial"},{"id":10705783,"url":"https://www.researchgate.net/publication/10705783_Outpatient_cognitive_Behavioral_pain_management_programs_A_randomized_comparison_of_a_group-based_multidisciplinary_versus_an_individual_therapy_model"},{"id":10667929,"url":"https://www.researchgate.net/publication/10667929_Royston_P_Mahesh_KB_Qian_WNovel_designs_for_multi-arm_clinical_trials_with_survival_outcomes_with_an_application_in_ovarian_cancer_Stat_Med_22_2239-2256"},{"id":10680695,"url":"https://www.researchgate.net/publication/10680695_Gemcitabine_Plus_Vinorelbine_Compared_With_Cisplatin_Plus_Vinorelbine_or_Cisplatin_Plus_Gemcitabine_for_Advanced_Non-Small-Cell_Lung_Cancer_A_Phase_III_Trial_of_the_Italian_GEMVIN_Investigators_and_th"},{"id":229590783,"url":"https://www.researchgate.net/publication/229590783_Sample_Size_Reassessment_in_Adaptive_Clinical_Trials_Using_a_Bias_Corrected_Estimate"},{"id":8935487,"url":"https://www.researchgate.net/publication/8935487_Sequential_methods_and_group_sequential_designs_for_comparative_clinical_trials"},{"id":9088700,"url":"https://www.researchgate.net/publication/9088700_Estimation_following_group-sequential_response-adaptive_clinical_trials"},{"id":9043986,"url":"https://www.researchgate.net/publication/9043986_Over-rulling_a_group_sequential_boundary_-_A_stopping_rule_versus_a_guideline"},{"id":9034761,"url":"https://www.researchgate.net/publication/9034761_An_Adaptive_Approach_to_Implementing_Bivariate_Group_Sequential_Clinical_Trial_Designs"},{"id":9034760,"url":"https://www.researchgate.net/publication/9034760_Data-Driven_Analysis_Strategies_for_Proportion_Studies_in_Adaptive_Group_Sequential_Test_Designs"},{"id":233242682,"url":"https://www.researchgate.net/publication/233242682_A_New_Interim_Monitoring_Statistic_for_Group_Sequential_Clinical_Trials"},{"id":227635128,"url":"https://www.researchgate.net/publication/227635128_An_application_of_a_multi-stage_strategy_involving_confidence_intervals_to_evaluate_whether_a_response_rate_is_favourable_or_not"},{"id":291792202,"url":"https://www.researchgate.net/publication/291792202_An_application_of_a_multi-stage_strategy_involving_confidence_intervals_to_evaluate_whether_a_response_rate_is_favourable_or_not"},{"id":7489550,"url":"https://www.researchgate.net/publication/7489550_Methodologic_issues_in_terminating_enrollment_of_a_subgroup_of_patients_in_a_multicenter_randomized_trial"},{"id":229701766,"url":"https://www.researchgate.net/publication/229701766_Modified_two-sided_normal_tolerance_intervals_for_batch_acceptance_of_dose_uniformity"},{"id":8643182,"url":"https://www.researchgate.net/publication/8643182_Increasing_sample_size_when_the_unblinded_interim_result_is_promising"},{"id":8589117,"url":"https://www.researchgate.net/publication/8589117_Triple-Nucleoside_Regimens_versus_Efavirenz-Containing_Regimens_for_the_Initial_Treatment_of_HIV-1_Infection"},{"id":4772197,"url":"https://www.researchgate.net/publication/4772197_Stepwise_likelihood_ratio_statistics_in_sequential_studies_Journal_of_the_Royal_Statistical_Society_66_401-409"},{"id":5265894,"url":"https://www.researchgate.net/publication/5265894_Withdrawal_of_Cyclosporine_or_Tacrolimus_After_Addition_of_Mycophenolate_Mofetil_in_Patients_With_Chronic_Allograft_Nephropathy"},{"id":8621169,"url":"https://www.researchgate.net/publication/8621169_The_advantages_and_disadvantages_of_adaptive_designs_for_clinical_trials"},{"id":8650819,"url":"https://www.researchgate.net/publication/8650819_Planning_of_clinical_trials"},{"id":277502434,"url":"https://www.researchgate.net/publication/277502434_Isayama_H_Komatsu_Y_Tsujino_T_et_al_A_prospective_randomised_study_of_covered_versus_uncovered_diamond_stents_for_the_management_of_distal_malignant_biliary_obstruction"},{"id":8589643,"url":"https://www.researchgate.net/publication/8589643_Construction_of_group_sequential_designs_in_clinical_trials_on_the_basis_of_detectable_treatment_differences"},{"id":8619878,"url":"https://www.researchgate.net/publication/8619878_A_prospective_randomized_study_of_'covered'_versus_'uncovered'_diamond_stents_for_the_management_of_distal_malignant_biliary_obstruction"},{"id":228034045,"url":"https://www.researchgate.net/publication/228034045_Brief_History_of_Clinical_Trials"},{"id":230124102,"url":"https://www.researchgate.net/publication/230124102_Choice_of_alpha_spending_function_and_time_points_in_clinical_trials_with_one_or_two_interim_analyses"},{"id":8423151,"url":"https://www.researchgate.net/publication/8423151_A_general_statistical_principle_for_changing_a_design_anytime_during_the_course_of_a_trial_Statistics_in_Medicineto_appear"},{"id":8246491,"url":"https://www.researchgate.net/publication/8246491_Monitoring_a_three-armed_clinical_trial_with_survival_endpoints_Fisher's_least_significant_difference_approach"},{"id":8373839,"url":"https://www.researchgate.net/publication/8373839_Optimal_Conditional_Error_Functions_for_the_Control_of_Conditional_Power"},{"id":8355231,"url":"https://www.researchgate.net/publication/8355231_Group_Sequential_Design_for_Comparative_Diagnostic_Accuracy_Studies_Implications_and_Guidelines_for_Practitioners"},{"id":222135235,"url":"https://www.researchgate.net/publication/222135235_Some_simple_corrected_confidence_intervals_following_a_sequential_test"},{"id":227635157,"url":"https://www.researchgate.net/publication/227635157_A_Bayesian_Randomized_Clinical_Trial_A_Decision_Theoretic_Sequential_Design"},{"id":229552220,"url":"https://www.researchgate.net/publication/229552220_Conditional_Maximum_Likelihood_Estimation_Following_a_Group_Sequential_Test"},{"id":233432608,"url":"https://www.researchgate.net/publication/233432608_Design_of_Group_Sequential_Clinical_Trials_with_Ordinal_Categorical_Data_Based_on_the_Mann-Whitney-Wilcoxon_Test"},{"id":8041653,"url":"https://www.researchgate.net/publication/8041653_Forward_and_Backward_Recurrence_Times_and_Length_Biased_Sampling_Age_Specific_Models"},{"id":241026915,"url":"https://www.researchgate.net/publication/241026915_Design_of_Clinical_Trials_Relating_to_Medical_Emergencies"},{"id":7820930,"url":"https://www.researchgate.net/publication/7820930_Repeated_looks_at_accumulating_data_To_correct_or_not_to_correct"},{"id":7722912,"url":"https://www.researchgate.net/publication/7722912_Self-Designing_Trial_Combined_with_Classical_Group_Sequential_Monitoring"},{"id":7350931,"url":"https://www.researchgate.net/publication/7350931_Group_sequential_methods_for_cluster_randomization_trials_with_binary_outcomes"},{"id":7350935,"url":"https://www.researchgate.net/publication/7350935_A_general_formulation_for_a_one-sided_group_sequential_design"},{"id":7722908,"url":"https://www.researchgate.net/publication/7722908_Two-Stage_Adaptive_Designs_with_Correlated_Test_Statistics"},{"id":8045823,"url":"https://www.researchgate.net/publication/8045823_Continuous_Positive_Airway_Pressure_for_Treatment_of_Postoperative_Hypoxemia"},{"id":228041122,"url":"https://www.researchgate.net/publication/228041122_Multiple_Testing_in_Clinical_Trials"},{"id":7929327,"url":"https://www.researchgate.net/publication/7929327_On_group_sequential_procedures_under_variance_heterogeneity"},{"id":7909001,"url":"https://www.researchgate.net/publication/7909001_Reducing_exposure_of_clinical_research_subjects_to_placebo_treatments"},{"id":7732352,"url":"https://www.researchgate.net/publication/7732352_Continuous_Toxicity_Monitoring_in_Phase_II_Trials_in_Oncology"},{"id":229523804,"url":"https://www.researchgate.net/publication/229523804_Sequential_Methods_for_Clinical_Trials"},{"id":228007102,"url":"https://www.researchgate.net/publication/228007102_Sequential_Analysis"},{"id":230504682,"url":"https://www.researchgate.net/publication/230504682_Data_Monitoring_Committees"},{"id":229945058,"url":"https://www.researchgate.net/publication/229945058_Interim_Analysis_of_Censored_Data"},{"id":227571169,"url":"https://www.researchgate.net/publication/227571169_Basic_Design_Considerations_for_Clinical_Trials_in_Oncology"},{"id":5207398,"url":"https://www.researchgate.net/publication/5207398_Bayesian_adaptive_design_for_clinical_trials"},{"id":7001414,"url":"https://www.researchgate.net/publication/7001414_Treatment_of_Acute_Bronchitis_in_Adults_With_a_Pelargonium_Sidoides_Preparation_EPsR_7630_A_Randomized_Double-Blind_Placebo-Controlled_Trial"},{"id":7669764,"url":"https://www.researchgate.net/publication/7669764_Two-stage_designs_for_experiments_with_a_large_number_of_hypotheses"},{"id":7492446,"url":"https://www.researchgate.net/publication/7492446_Noninvasive_ventilation_to_prevent_respiratory_failure_after_extubation_in_high-risk_patients_Crit_Care_Med"},{"id":227032602,"url":"https://www.researchgate.net/publication/227032602_Statistische_Bewertung_von_Therapieergebnissen"},{"id":242077682,"url":"https://www.researchgate.net/publication/242077682_GROUP_SEQUENTIAL_TEST_OF_STRATIFIED_NON-PARAMETRIC_STATISTICS_FOR_SURVIVAL_DATA"},{"id":253879216,"url":"https://www.researchgate.net/publication/253879216_AN_INVESTIGATION_OF_TWO-STAGE_TESTS"},{"id":265679257,"url":"https://www.researchgate.net/publication/265679257_Data_Monitoring_in_Clinical_Trials_A_Case_Studies_Approach"},{"id":229078924,"url":"https://www.researchgate.net/publication/229078924_Data_Monitoring_in_Clinical_Trials"},{"id":228877994,"url":"https://www.researchgate.net/publication/228877994_Estimation_following_a_group_sequential_test_for_distributions_in_the_one-parameter_exponential_family"},{"id":6494540,"url":"https://www.researchgate.net/publication/6494540_Design_issues_in_initial_HIV-treatment_trials_focus_on_ACTG_A5095"},{"id":226455682,"url":"https://www.researchgate.net/publication/226455682_Sequential_Analysis_of_Quality_of_Life_Rasch_Measurements"},{"id":226794548,"url":"https://www.researchgate.net/publication/226794548_Degradation-Threshold-Shock_Models"},{"id":228709246,"url":"https://www.researchgate.net/publication/228709246_A_field_experiment_to_measure_agency_problems_in_auto_repair"},{"id":51374316,"url":"https://www.researchgate.net/publication/51374316_Adjuvant_Docetaxel_or_Vinorelbine_with_or_without_Trastuzumab_for_Breast_Cancer"},{"id":247529897,"url":"https://www.researchgate.net/publication/247529897_A_Review_of_Analysis_of_Clinical_Trials_Using_SAS_A_Practical_Guide_by_A_Dmitrienko_G_Molenberghs_C_Chuang-Stein_and_W_Offen"},{"id":225129904,"url":"https://www.researchgate.net/publication/225129904_IEGM-online_based_evaluation_of_implantable_cardioverter_defibrillator_therapy_appropriateness"},{"id":6715536,"url":"https://www.researchgate.net/publication/6715536_Planning_for_an_adaptive_design_a_case_study_in_COPD"},{"id":230576923,"url":"https://www.researchgate.net/publication/230576923_Pivotal_Quantities_Based_on_Sequential_Data_A_Bootstrap_Approach_Clinical_Trials_and_Analysis_Pivotal_Quantities_Based_on_Sequential_Data_A_Bootstrap_Approach"},{"id":229879678,"url":"https://www.researchgate.net/publication/229879678_A_class_of_sequential_tests_for_two-sample_composite_hypotheses"},{"id":23173693,"url":"https://www.researchgate.net/publication/23173693_New_pathways_for_evaluating_potential_acute_stroke_therapies"},{"id":7066521,"url":"https://www.researchgate.net/publication/7066521_Comparison_of_Two_Fluid-Management_Strategies_in_Acute_Lung_Injury"},{"id":6817815,"url":"https://www.researchgate.net/publication/6817815_Repeated_Confidence_Intervals_in_Self-Designing_Clinical_Trials_and_Switching_between_Noninferiority_and_Superiority"},{"id":6817819,"url":"https://www.researchgate.net/publication/6817819_A_Brief_Review_on_Software_Developments_for_Group_Sequential_and_Adaptive_Designs"},{"id":6817796,"url":"https://www.researchgate.net/publication/6817796_Flexible_Designs_by_Adaptive_Plans_of_Generalized_Pocock-_and_O'Brien-Fleming-Type_and_by_Self-Designing_Clinical_Trials"},{"id":6817795,"url":"https://www.researchgate.net/publication/6817795_An_Overview_of_Statistical_Approaches_for_Adaptive_Designs_and_Design_Modifications"},{"id":233161845,"url":"https://www.researchgate.net/publication/233161845_LERCHE'S_SEQUENTIAL_TEST_FOR_THE_DRIFT_OF_A_BROWNIAN_MOTION_WITH_A_SMOOTH_PRIOR"},{"id":264355466,"url":"https://www.researchgate.net/publication/264355466_Discussions"},{"id":264213523,"url":"https://www.researchgate.net/publication/264213523_Discussions"},{"id":264402106,"url":"https://www.researchgate.net/publication/264402106_Discussions"},{"id":264402233,"url":"https://www.researchgate.net/publication/264402233_Discussions"},{"id":5207478,"url":"https://www.researchgate.net/publication/5207478_Confidence_intervals_in_group_sequential_trials_with_random_group_sizes_and_applications_to_survival_analysis_Biometrika"},{"id":7373577,"url":"https://www.researchgate.net/publication/7373577_Sequential_genomewide_association_studies_for_monitoring_adverse_events_in_clinical_evaluation_of_new_drugs"},{"id":233166167,"url":"https://www.researchgate.net/publication/233166167_Pivotal_Quantities_Based_on_Sequential_Data_A_Bootstrap_Approach"},{"id":6810698,"url":"https://www.researchgate.net/publication/6810698_Are_Flexible_Designs_Sound"},{"id":6852210,"url":"https://www.researchgate.net/publication/6852210_Ocular_Decompression_Devices_Liquid_Mercury_Balloon_vs_the_Tungsten_Powder_Balloon"},{"id":6880035,"url":"https://www.researchgate.net/publication/6880035_Issues_in_the_use_of_adaptive_clinical_trial_designs"},{"id":6861534,"url":"https://www.researchgate.net/publication/6861534_Information-based_monitoring_of_clinical_trials"},{"id":6713220,"url":"https://www.researchgate.net/publication/6713220_Rhinosinusitis_Developing_guidance_for_clinical_trials"},{"id":226769511,"url":"https://www.researchgate.net/publication/226769511_SCPRT_A_Sequential_Procedure_That_Gives_Another_Reason_to_Stop_Clinical_Trials_Early"},{"id":226967979,"url":"https://www.researchgate.net/publication/226967979_Where_Next_for_Evidence_Synthesis_of_Prognostic_Marker_Studies_Improving_the_Quality_and_Reporting_of_Primary_Studies_to_Facilitate_Clinically_Relevant_Evidence-Based_Results"},{"id":225317760,"url":"https://www.researchgate.net/publication/225317760_Cancer_Clinical_Trials_with_Efficacy_and_Toxicity_Endpoints_A_Simulation_Study_to_Compare_Two_Nonparametric_Methods"},{"id":226218963,"url":"https://www.researchgate.net/publication/226218963_The_Role_of_Correlated_Frailty_Models_in_Studies_of_Human_Health_Ageing_and_Longevity"},{"id":226339725,"url":"https://www.researchgate.net/publication/226339725_Spontaneous_Reporting_System_Modelling_for_the_Evaluation_of_Automatic_Signal_Generation_Methods_in_Pharmacovigilance"},{"id":226686951,"url":"https://www.researchgate.net/publication/226686951_Prognostic_Factors_and_Prediction_of_Residual_Survival_for_Hospitalized_Elderly_Patients"},{"id":227108457,"url":"https://www.researchgate.net/publication/227108457_A_Parametric_Degradation_Model_Used_in_Reliability_Survival_Analysis_and_Quality_of_Life"},{"id":225235264,"url":"https://www.researchgate.net/publication/225235264_New_Models_and_Methods_for_Survival_Analysis_of_Experimental_Data"},{"id":225906067,"url":"https://www.researchgate.net/publication/225906067_Qualitative_Risk_Analysis_in_Animal_Health_A_Methodological_Example"},{"id":226646911,"url":"https://www.researchgate.net/publication/226646911_Uniform_Consistency_for_Conditional_Lifetime_Distribution_Estimators_Under_Random_Right-Censorship"},{"id":226817464,"url":"https://www.researchgate.net/publication/226817464_Longitudinal_Analysis_of_Short-Term_Bronchiolitis_Air_Pollution_Association_Using_Semiparametric_Models"},{"id":227248627,"url":"https://www.researchgate.net/publication/227248627_Sentinel_Event_Methods_for_Monitoring_Unanticipated_Adverse_Events"},{"id":232292731,"url":"https://www.researchgate.net/publication/232292731_Variance_Estimation_of_a_Survival_Function_with_Doubly_Censored_Failure_Time_Data"},{"id":225827558,"url":"https://www.researchgate.net/publication/225827558_Agreement_Between_Two_Ratings_with_Different_Ordinal_Scales"},{"id":225968462,"url":"https://www.researchgate.net/publication/225968462_Assessing_Drug_Resistance_in_HIV_Infection_Using_Viral_Load_Using_Segmented_Regression"},{"id":226425968,"url":"https://www.researchgate.net/publication/226425968_Swiss_Federal_Veterinary_Office_Risk_Assessments_Advantages_and_Limitations_of_The_Qualitative_Method"},{"id":226428512,"url":"https://www.researchgate.net/publication/226428512_Design_of_Multicentre_Clinical_Trials_with_Random_Enrolment"},{"id":226434980,"url":"https://www.researchgate.net/publication/226434980_Statistical_Methods_for_Combining_Clinical_Trial_Phases_II_And_III"},{"id":226589753,"url":"https://www.researchgate.net/publication/226589753_Neural_Networks_An_Application_for_Predicting_Smear_Negative_Pulmonary_Tuberculosis"},{"id":226752932,"url":"https://www.researchgate.net/publication/226752932_Latent_Covariates_in_Generalized_Linear_Models_A_Rasch_Model_Approach"},{"id":226930640,"url":"https://www.researchgate.net/publication/226930640_Assessment_of_Treatment_Effects_on_HIV_Pathogenesis_Under_Treatment_By_State_Space_Models"},{"id":227013161,"url":"https://www.researchgate.net/publication/227013161_Systematic_Review_of_Multiple_Studies_of_Prognosis_The_Feasibility_of_Obtaining_Individual_Patient_Data"},{"id":227172017,"url":"https://www.researchgate.net/publication/227172017_Sequential_Estimation_for_the_Semiparametric_Additive_Hazard_Model"},{"id":232633305,"url":"https://www.researchgate.net/publication/232633305_A_Group_Sequential_Procedure_for_Continuous_Longitudinal_Data_in_Multi-Armed_Trials"},{"id":254087697,"url":"https://www.researchgate.net/publication/254087697_Data_Monitoring_in_Clinical_Trials_Using_Prediction"},{"id":254087703,"url":"https://www.researchgate.net/publication/254087703_On_the_Efficiency_of_Interim_Analyses_Applied_to_Nonclinical_Studies"},{"id":5802140,"url":"https://www.researchgate.net/publication/5802140_Intravitreal_bevacizumab_Avastin_injection_alone_or_combined_with_triamcinolone_versus_macular_photocoagulation_as_primary_treatment_of_diabetic_macular_edema"},{"id":262870597,"url":"https://www.researchgate.net/publication/262870597_Homoopathie_bei_akuter_Rhinosinusitis_Eine_doppelblinde_placebokontrollierte_Studie_belegt_die_Wirksamkeit_und_Vertraglichkeit_eines_homoopathischen_Kombinationsarzneimittels"},{"id":6665324,"url":"https://www.researchgate.net/publication/6665324_Pretreatment_with_intracoronary_adenosine_reduces_the_incidence_of_myonecrosis_after_non-urgent_percutaneous_coronary_intervention_A_prospective_randomized_study"},{"id":233179756,"url":"https://www.researchgate.net/publication/233179756_Nonparametric_Sequential_Comparison_of_Two_Treatments_with_Random_Allocation"},{"id":6658674,"url":"https://www.researchgate.net/publication/6658674_A_25-year_review_of_sequential_methodology_in_clinical_studies"},{"id":5957168,"url":"https://www.researchgate.net/publication/5957168_A_Procedure_for_Group_Sequential_Comparative_Poisson_Trials"},{"id":5861054,"url":"https://www.researchgate.net/publication/5861054_Honigmann_P_Fischer_H_Kurmann_A_et_alInvestigating_the_effect_of_intra-operative_infiltration_with_local_anaesthesia_on_the_development_of_chronic_postoperative_pain_after_inguinal_hernia_repair_A_ran"},{"id":6479774,"url":"https://www.researchgate.net/publication/6479774_Bayesian_decision-theoretic_group_sequential_clinical_trial_design_based_on_a_quadratic_loss_function_A_frequentist_evaluation"},{"id":5820506,"url":"https://www.researchgate.net/publication/5820506_Strategies_for_Including_Patients_Recruited_During_Interim_Analysis_of_Clinical_Trials"},{"id":5804479,"url":"https://www.researchgate.net/publication/5804479_Monitoring_rare_serious_adverse_events_from_a_new_treatment_and_testing_for_a_difference_from_historical_controls"},{"id":5820505,"url":"https://www.researchgate.net/publication/5820505_Statistical_Considerations_for_Testing_Multiple_Endpoints_in_Group_Sequential_or_Adaptive_Clinical_Trials"},{"id":5820507,"url":"https://www.researchgate.net/publication/5820507_Adaptive_Group_Sequential_Test_for_Clinical_Trials_with_Changing_Patient_Population"},{"id":6542048,"url":"https://www.researchgate.net/publication/6542048_Nonconventional_clinical_trial_designs_approaches_to_provide_more_precise_estimates_of_treatment_effects_with_a_smaller_sample_size_but_at_a_cost"},{"id":6885805,"url":"https://www.researchgate.net/publication/6885805_Performance_of_adaptive_sample_size_adjustment_with_respect_to_stopping_criteria_and_time_of_interim_analysis"},{"id":6618973,"url":"https://www.researchgate.net/publication/6618973_Homeopathy_in_acute_rhinosinusitis_a_double-blind_placebo_controlled_study_shows_the_efficiency_and_tolerability_of_a_homeopathic_combination_remedy"},{"id":6996217,"url":"https://www.researchgate.net/publication/6996217_Adaptive_design_estimation_and_inference_with_censored_data_in_a_semiparametric_model"},{"id":227986066,"url":"https://www.researchgate.net/publication/227986066_The_Development_of_Clinical_Trials"},{"id":6215413,"url":"https://www.researchgate.net/publication/6215413_Robustness_of_an_Odds-ratio_Test_in_a_Stratified_Group_Sequential_Trial_with_a_Binary_Outcome_Measure"},{"id":6474491,"url":"https://www.researchgate.net/publication/6474491_Methods_of_joint_evaluation_of_efficacy_and_toxicity_in_phase_II_clinical_trials"},{"id":6159401,"url":"https://www.researchgate.net/publication/6159401_Adaptive_Trial_Design"},{"id":51382422,"url":"https://www.researchgate.net/publication/51382422_Transition_from_IV_epoprostenol_to_subcutaneous_treprostinil_in_pulmonary_arterial_hypertension_A_controlled_trial"},{"id":6393267,"url":"https://www.researchgate.net/publication/6393267_Group_sequential_t-test_for_clinical_trials_with_small_sample_sizes_across_stages"},{"id":228043386,"url":"https://www.researchgate.net/publication/228043386_The_Textbook_of_Pharmaceutical_Medicine_Fifth_Edition"},{"id":6297264,"url":"https://www.researchgate.net/publication/6297264_Sequential_evaluation_of_a_medical_diagnostic_test_with_binary_outcomes"},{"id":5885842,"url":"https://www.researchgate.net/publication/5885842_Tansient_neurological_symptoms_after_isobaric_subarachnold_anesthesia_with_2_lidocaine_The_impact_of_needle_type"},{"id":6262828,"url":"https://www.researchgate.net/publication/6262828_Frequentist_evaluation_of_group_sequential_designs"},{"id":229760419,"url":"https://www.researchgate.net/publication/229760419_Group_Sequential_Designs"},{"id":230513488,"url":"https://www.researchgate.net/publication/230513488_Interim_Analyses"},{"id":241068823,"url":"https://www.researchgate.net/publication/241068823_18_Definitive_Phase_III_and_Phase_IV_Clinical_Trials"},{"id":227253787,"url":"https://www.researchgate.net/publication/227253787_Bayesian_Versus_Frequentist_Inference"},{"id":226775326,"url":"https://www.researchgate.net/publication/226775326_Sequential_Analysis_of_Quality-of-Life_Measurements_Using_Mixed_Rasch_Models"},{"id":225199125,"url":"https://www.researchgate.net/publication/225199125_Goodness-of-Fit_Tests_for_Pareto_Distribution"},{"id":226044465,"url":"https://www.researchgate.net/publication/226044465_Optimal_Two-Treatment_Repeated_Measurement_Designs_for_Two_Periods"},{"id":226281528,"url":"https://www.researchgate.net/publication/226281528_Optimal_Incomplete_Maintenance_for_Weibull_Failure_Processes"},{"id":226313964,"url":"https://www.researchgate.net/publication/226313964_Nonparametric_Estimation_of_Integral_Functionals_for_Semi-Markov_Processes_with_Application_in_Reliability"},{"id":226688187,"url":"https://www.researchgate.net/publication/226688187_Measuring_Degradation_of_Quality-of-Life_Related_to_Pollution_in_the_SEQAP_Study"},{"id":226273735,"url":"https://www.researchgate.net/publication/226273735_Clinical_Trials_and_the_Genomic_Evolution_Some_Statistical_Perspectives"},{"id":226423735,"url":"https://www.researchgate.net/publication/226423735_Multistate_System_Reliability_Assessment_by_Using_the_Markov_Reward_Model"},{"id":226778186,"url":"https://www.researchgate.net/publication/226778186_Are_Nonhomogeneous_Poisson_Process_Models_Preferable_to_General-Order_Statistics_Models_for_Software_Reliability_Estimation"},{"id":5766165,"url":"https://www.researchgate.net/publication/5766165_Wetterslev_J_Thorlund_K_Brok_J_et_al_Trial_sequential_analysis_may_establish_when_firm_evidence_is_reached_in_cumulative_meta-analysis"},{"id":254084288,"url":"https://www.researchgate.net/publication/254084288_So_you_want_to_run_an_experiment_now_what_An_Introduction_to_Optimal_Sample_Arrangements"},{"id":225777705,"url":"https://www.researchgate.net/publication/225777705_A_group_sequential_test_for_the_inverse_Gaussian_mean"},{"id":6449149,"url":"https://www.researchgate.net/publication/6449149_Wilcoxon-based_group_sequential_designs_for_comparison_of_areas_under_two_correlated_ROC_curves"},{"id":233317953,"url":"https://www.researchgate.net/publication/233317953_Weighted_Logrank_Statistics_in_Sequential_Tests"},{"id":245495899,"url":"https://www.researchgate.net/publication/245495899_Editor's_Special_Invited_Paper_Second-Guessing_Clinical_Trial_Designs"},{"id":5569284,"url":"https://www.researchgate.net/publication/5569284_Interim_futility_analysis_with_intermediate_endpoints"},{"id":5476255,"url":"https://www.researchgate.net/publication/5476255_Maintaining_confidentiality_of_interim_data_to_enhance_trial_integrity_and_credibility"},{"id":5687019,"url":"https://www.researchgate.net/publication/5687019_Practical_Bayesian_Design_and_Analysis_for_Drug_and_Device_Clinical_Trials"},{"id":4743537,"url":"https://www.researchgate.net/publication/4743537_A_Uniform_Improvement_of_Bonferroni-Type_Tests_by_Sequential_Tests"},{"id":229767808,"url":"https://www.researchgate.net/publication/229767808_The_design_of_clinical_trials"},{"id":5481755,"url":"https://www.researchgate.net/publication/5481755_Nonparametric_and_Semiparametric_Group_Sequential_Methods_for_Comparing_Accuracy_of_Diagnostic_Tests"},{"id":6263008,"url":"https://www.researchgate.net/publication/6263008_Two-Stage_Designs_for_Dose-Finding_Trials_with_a_Biologic_Endpoint_Using_Stepwise_Tests"},{"id":6550421,"url":"https://www.researchgate.net/publication/6550421_A_two-stage_phase_II_trial_design_utilizing_both_primary_and_secondary_endpoints"},{"id":6158334,"url":"https://www.researchgate.net/publication/6158334_Dynamic_Comparison_of_Kaplan-Meier_Proportions_Monitoring_a_Randomized_Clinical_Trial_with_a_Long-Term_Binary_Endpoint"},{"id":5473612,"url":"https://www.researchgate.net/publication/5473612_Comparison_of_2_interventions_for_liquid_aspiration_on_pneumonia_incidence_A_randomized_trial"},{"id":5537800,"url":"https://www.researchgate.net/publication/5537800_Efficient_ways_to_obtain_the_optimal_sample_size_in_clinical_trials_in_rare_diseases"},{"id":5611229,"url":"https://www.researchgate.net/publication/5611229_Adaptive_dose_finding_based_on_t-statistic_for_dose-response_trials"},{"id":5611227,"url":"https://www.researchgate.net/publication/5611227_Nonparametric_sequential_evaluation_of_diagnostic_biomarkers"},{"id":230304570,"url":"https://www.researchgate.net/publication/230304570_Lan-DeMets_Alpha-Spending_Function"},{"id":5264707,"url":"https://www.researchgate.net/publication/5264707_Bayesian_interim_analysis_in_clinical_trials"},{"id":254087754,"url":"https://www.researchgate.net/publication/254087754_Evaluation_of_Some_Alternative_Designs_for_Phase_2_Multiple_Sclerosis_Trials-A_Simulation_Study"},{"id":5527440,"url":"https://www.researchgate.net/publication/5527440_Two-Stage_Group_Sequential_Robust_Tests_in_Family-Based_Association_Studies_Controlling_Type_I_Error"},{"id":23134355,"url":"https://www.researchgate.net/publication/23134355_Group_Sequential_and_Adaptive_Designs_-_A_Review_of_Basic_Concepts_and_Points_of_Discussion"},{"id":30861491,"url":"https://www.researchgate.net/publication/30861491_Adaptive_Survey_Design_to_Reduce_Nonresponse_Bias"},{"id":5441727,"url":"https://www.researchgate.net/publication/5441727_Brok_J_Thorlund_K_Gluud_C_et_al_Trial_sequential_analysis_reveals_insufficient_information_size_and_potentially_false_positive_results_in_many_meta-analyses"},{"id":51413464,"url":"https://www.researchgate.net/publication/51413464_Assessment_of_Early_Continence_After_Reconstruction_of_the_Periprostatic_Tissues_in_Patients_Undergoing_Computer_Assisted_Robotic_Prostatectomy_Results_of_a_2_Group_Parallel_Randomized_Controlled_Tria"},{"id":1773587,"url":"https://www.researchgate.net/publication/1773587_A_New_Framework_of_Multistage_Estimation"},{"id":5408625,"url":"https://www.researchgate.net/publication/5408625_Optimized_multi-stage_designs_controlling_the_false_discovery_or_the_family-wise_error_rate"},{"id":232090770,"url":"https://www.researchgate.net/publication/232090770_Alternative_Designs_for_Clinical_Trials"},{"id":6128683,"url":"https://www.researchgate.net/publication/6128683_Sequential_design_approaches_for_bioequivalence_studies_with_crossover_designs"},{"id":23406429,"url":"https://www.researchgate.net/publication/23406429_Assessment_of_Medical_Management_Outcomes_in_Small_Populations"},{"id":23218895,"url":"https://www.researchgate.net/publication/23218895_Bayesian_adaptive_model_selection_for_optimizing_group_sequential_clinical_trials"},{"id":51435502,"url":"https://www.researchgate.net/publication/51435502_Considerations_in_Adapting_Clinical_Trial_Design"},{"id":225212171,"url":"https://www.researchgate.net/publication/225212171_Zwischenauswertungen_und_statistisches_Monitoring_der_Ergebnisse_von_klinischen_Studien"},{"id":26828897,"url":"https://www.researchgate.net/publication/26828897_The_application_of_bespoke_spending_functions_in_group-sequential_designs_and_the_effect_of_delayed_treatment_switching_in_survival_trials"},{"id":26892598,"url":"https://www.researchgate.net/publication/26892598_Hierachical_testing_of_multiple_endpoints_in_group_sequential_trials"},{"id":26844655,"url":"https://www.researchgate.net/publication/26844655_DISENOS_ADAPTATIVOS_PARA_ENSAYOS_CLINICOS_FASE_II_O_III_EN_PACIENTES_CON_CANCER_EN_CUBA"},{"id":232655829,"url":"https://www.researchgate.net/publication/232655829_Analysis_of_Longitudinal_Ordinal_Data_with_Drop-Outs"},{"id":23629756,"url":"https://www.researchgate.net/publication/23629756_A_random_walk_approach_for_quantifying_uncertainty_in_group_sequential_survival_trials"},{"id":24026396,"url":"https://www.researchgate.net/publication/24026396_Human_Polymerized_Hemoglobin_for_the_Treatment_of_Hemorrhagic_Shock_when_Blood_Is_Unavailable_The_USA_Multicenter_Trial"},{"id":23655389,"url":"https://www.researchgate.net/publication/23655389_Commentary_Which_meta-analyses_are_conclusive"},{"id":24254032,"url":"https://www.researchgate.net/publication/24254032_Stopping_trials_for_efficacy_An_almost_unbiased_view"},{"id":238339898,"url":"https://www.researchgate.net/publication/238339898_Nonproportional_Hazards_and_the_Power_of_Sequential_Trials"},{"id":28358227,"url":"https://www.researchgate.net/publication/28358227_Adaptive_controlled_noninferiority_group_sequential_trials"},{"id":28358225,"url":"https://www.researchgate.net/publication/28358225_A_confidence_interval_approach_for_difference_and_ratio_of_normal_means_in_self-designing_clinical_trials"},{"id":28358229,"url":"https://www.researchgate.net/publication/28358229_Standardized_mean_differences_in_adaptive_group_sequential_trials"},{"id":246618447,"url":"https://www.researchgate.net/publication/246618447_Disenos_secuenciales_y_analisis_intermedio_en_la_investigacion_clinica_tamano_frente_a_dificultad"},{"id":245697853,"url":"https://www.researchgate.net/publication/245697853_BCG_versus_Photodynamische_Therapie_PDT_beim_nicht_muskelinvasiven_Harnblasenkarzinom_-_eine_multizentrische_Phase-III-Studie"},{"id":23972610,"url":"https://www.researchgate.net/publication/23972610_Optimizing_Trial_Design_Sequential_Adaptive_and_Enrichment_Strategies"},{"id":23799327,"url":"https://www.researchgate.net/publication/23799327_Dose_Selection_in_Seamless_Phase_IIIII_Clinical_Trials_Based_on_Efficacy_and_Safety"},{"id":23569473,"url":"https://www.researchgate.net/publication/23569473_Multicenter_Double-Blind_Randomized_Placebo-Controlled_Trial_Assessing_the_Efficacy_and_Safety_of_Proton_Pump_Inhibitor_Lansoprazole_in_Infants_with_Symptoms_of_Gastroesophageal_Reflux_Disease"},{"id":24307594,"url":"https://www.researchgate.net/publication/24307594_Randomized_Trial_of_Intravitreal_Bevacizumab_Alone_or_Combined_with_Triamcinolone_versus_Macular_Photocoagulation_in_Diabetic_Macular_Edema"},{"id":23996775,"url":"https://www.researchgate.net/publication/23996775_Adaptive_Designs_for_Confirmatory_Clinical_Trials"},{"id":24253486,"url":"https://www.researchgate.net/publication/24253486_The_USA_Multicenter_Prehosptial_Hemoglobin-based_Oxygen_Carrier_Resuscitation_Trial_Scientific_Rationale_Study_Design_and_Results"},{"id":226080890,"url":"https://www.researchgate.net/publication/226080890_Further_Comments_on_the_Alpha-Spending_Function"},{"id":24360299,"url":"https://www.researchgate.net/publication/24360299_A_prospective_randomized_double-blind_placebo-controlled_trial_of_multimodal_intraoperative_analgesia_for_laparoscopic_excision_of_endometriosis"},{"id":23654894,"url":"https://www.researchgate.net/publication/23654894_Early_Stopping_Rules_in_Clinical_Trials_Based_on_Sequential_Monitoring_of_Serious_Adverse_Events"},{"id":24238922,"url":"https://www.researchgate.net/publication/24238922_Using_short-term_response_information_to_facilitate_adaptive_randomization_for_survival_clinical_trials_Stat_Med_28121680-1689_DOI_101002sim3578"},{"id":232934311,"url":"https://www.researchgate.net/publication/232934311_A_simulation_study_on_power_comparisons_for_group_sequential_tests_of_non-parametric_statistics"},{"id":26252149,"url":"https://www.researchgate.net/publication/26252149_Adverse_effects_of_combined_spinal-epidural_versus_traditional_epidural_analgesia"},{"id":46493962,"url":"https://www.researchgate.net/publication/46493962_Group_sequential_testing_of_homogeneity_in_genetic_linkage_analysis"},{"id":232096233,"url":"https://www.researchgate.net/publication/232096233_Levosimendan_is_superior_to_enoximone_in_refractory_cardiogenic_shock_complicating_acute_myocardial_infarction_Reply"},{"id":233072341,"url":"https://www.researchgate.net/publication/233072341_Sequential_Tests_and_Change_Detection_in_the_Covariance_Structure_of_Weakly_Stationary_Time_Series"},{"id":38083087,"url":"https://www.researchgate.net/publication/38083087_Adjuvant_capecitabine_in_combination_with_docetaxel_and_cyclophosphamide_plus_epirubicin_for_breast_cancer_an_open-label_randomised_controlled_trial"},{"id":38062630,"url":"https://www.researchgate.net/publication/38062630_Fluorouracil_Epirubicin_and_Cyclophosphamide_With_Either_Docetaxel_or_Vinorelbine_With_or_Without_Trastuzumab_As_Adjuvant_Treatments_of_Breast_Cancer_Final_Results_of_the_FinHer_Trial"},{"id":226168854,"url":"https://www.researchgate.net/publication/226168854_Prinzipien_der_Statistik_und_Studienbiometrie"},{"id":225268019,"url":"https://www.researchgate.net/publication/225268019_Adaptive_group_sequential_confidence_intervals_for_the_ratio_of_normal_means"},{"id":46467179,"url":"https://www.researchgate.net/publication/46467179_So_you_want_to_run_an_experiment_now_what_Some_Simple_Rules_of_Thumb_for_Optimal_Experimental_Design"},{"id":41508812,"url":"https://www.researchgate.net/publication/41508812_Design_of_adaptive_two-stage_double-arm_clinical_trials_for_dichotomous_variables"},{"id":42587755,"url":"https://www.researchgate.net/publication/42587755_Testing_a_Primary_and_a_Secondary_Endpoint_in_a_Group_Sequential_Design"},{"id":225905678,"url":"https://www.researchgate.net/publication/225905678_Clinical_Trials_for_Rare_Lung_Diseases"},{"id":229560918,"url":"https://www.researchgate.net/publication/229560918_Monitoring"},{"id":41827090,"url":"https://www.researchgate.net/publication/41827090_The_dual_test_Safeguarding_p-value_combination_tests_for_adaptive_designs"},{"id":227643659,"url":"https://www.researchgate.net/publication/227643659_Optimal_group-sequential_designs_for_simultaneous_testing_of_superiority_and_non-inferiority"},{"id":220504808,"url":"https://www.researchgate.net/publication/220504808_Operating_Characteristics_for_Group_Sequential_Trials_Monitored_Under_Fractional_Brownian_Motion"},{"id":43049089,"url":"https://www.researchgate.net/publication/43049089_Cardiovascular_and_Metabolic_Effects_of_High-dose_Insulin_in_a_Porcine_Septic_Shock_Model"},{"id":220505025,"url":"https://www.researchgate.net/publication/220505025_Development_of_Adaptive_Group_Sequential_Procedure_for_Changing_Sample_Size"},{"id":247807381,"url":"https://www.researchgate.net/publication/247807381_Adaptive_Choice_of_Group_Sequential_Boundary"},{"id":229690532,"url":"https://www.researchgate.net/publication/229690532_From_Evidence-Based_Economics_to_Economics-Based_Evidence_Using_Systematic_Review_to_Inform_the_Design_of_Future_Research"},{"id":220363696,"url":"https://www.researchgate.net/publication/220363696_Group_sequential_tests_under_fractional_Brownian_motion_in_monitoring_clinical_trials"},{"id":43348087,"url":"https://www.researchgate.net/publication/43348087_A_flexible_futility_monitoring_method_with_time-varying_conditional_power_boundary"},{"id":44898021,"url":"https://www.researchgate.net/publication/44898021_Flexible_Designs_in_klinischen_Prufungen_mit_binarer_und_ordinaler_Zielvariable"},{"id":45377851,"url":"https://www.researchgate.net/publication/45377851_Adaptive_Group_Sequential_Trials_with_the_Standardized_Mean_Difference_as_Effect_Size"},{"id":45289417,"url":"https://www.researchgate.net/publication/45289417_Response-adaptive_randomization_for_clinical_trials_with_adjustment_for_covariate_imbalance"},{"id":45289419,"url":"https://www.researchgate.net/publication/45289419_Some_drop-the-loser_designs_for_monitoring_multiple_doses"},{"id":45276514,"url":"https://www.researchgate.net/publication/45276514_A_group_sequential_type_design_for_three-arm_non-inferiority_trials_with_binary_endpoints"},{"id":232740012,"url":"https://www.researchgate.net/publication/232740012_A_Comparison_of_Testing_Parameters_and_the_Implementation_of_a_Group_Sequential_Design_for_Equivalence_Studies_Using_Paired-Sample_Analysis"},{"id":46578348,"url":"https://www.researchgate.net/publication/46578348_Group_sequential_trials_revisitedSimple_implementation_using_SAS"},{"id":226362573,"url":"https://www.researchgate.net/publication/226362573_Monitoring_Response_Variables"},{"id":230736707,"url":"https://www.researchgate.net/publication/230736707_A_new_statistical_trend_in_clinical_research_-_Bayesian_statistics"},{"id":47532329,"url":"https://www.researchgate.net/publication/47532329_Addition_of_phenylephrine_to_high-dose_insulin_in_dihydropyridine_overdose_does_not_improve_outcome"},{"id":47451734,"url":"https://www.researchgate.net/publication/47451734_Sequential_Monitoring_of_Response-Adaptive_Randomized_Clinical_Trials"},{"id":28358228,"url":"https://www.researchgate.net/publication/28358228_Adaptive_confidence_intervals_of_desired_length_and_power_for_normal_means"},{"id":227268673,"url":"https://www.researchgate.net/publication/227268673_Approximating_probabilities_of_correlated_events"},{"id":223769575,"url":"https://www.researchgate.net/publication/223769575_Minimum_sample_size_determination_of_vibration_signals_in_machine_learning_approach_to_fault_diagnosis_using_power_analysis"},{"id":47636627,"url":"https://www.researchgate.net/publication/47636627_Combining_an_Internal_Pilot_with_an_Interim_Analysis_for_Single_Degree_of_Freedom_Tests"},{"id":225215420,"url":"https://www.researchgate.net/publication/225215420_Sequential_Testing_with_Recurrent_Events_over_Multiple_Treatment_Periods"},{"id":49682332,"url":"https://www.researchgate.net/publication/49682332_Effect_of_a_Lung_Protective_Strategy_for_Organ_Donors_on_Eligibility_and_Availability_of_Lungs_for_Transplantation_A_Randomized_Controlled_Trial"},{"id":49680409,"url":"https://www.researchgate.net/publication/49680409_Impacts_on_type_I_error_rate_with_inappropriate_use_of_learn_and_confirm_in_confirmatory_adaptive_design_trials"},{"id":251645592,"url":"https://www.researchgate.net/publication/251645592_P26_An_individualized_target-driven_treatment_regimen_for_children_with_idiopathic_short_stature_ISS"},{"id":226973985,"url":"https://www.researchgate.net/publication/226973985_Phase_III_Clinical_Trials_with_Anticancer_Agents"},{"id":226675056,"url":"https://www.researchgate.net/publication/226675056_Adaptive_Trial_Designs"},{"id":51083605,"url":"https://www.researchgate.net/publication/51083605_Sequential_interim_analysis_of_survival_of_data_in_DNA_microarray_experiments_BMC_Bioinformatics_29127"},{"id":229963082,"url":"https://www.researchgate.net/publication/229963082_Sequential_diagnostic_trial_designs"},{"id":51550194,"url":"https://www.researchgate.net/publication/51550194_Minimizing_Animal_Numbers_The_Variable-Criteria_Sequential_Stopping_Rule"},{"id":51609875,"url":"https://www.researchgate.net/publication/51609875_Small_Sample_Approach_and_Statistical_and_Epidemiological_Aspects"},{"id":254354986,"url":"https://www.researchgate.net/publication/254354986_Statistical_Inference_in_Adaptive_Group_Sequential_Trials_with_the_Standardized_Mean_Difference_as_Effect_Size"},{"id":50348063,"url":"https://www.researchgate.net/publication/50348063_Randomized_Double-Blind_Trial_of_Sulindac_and_Etodolac_to_Eradicate_Aberrant_Crypt_Foci_and_to_Prevent_Sporadic_Colorectal_Polyps"},{"id":50939025,"url":"https://www.researchgate.net/publication/50939025_A_comparison_of_two_worlds_How_does_Bayes_hold_up_to_the_status_quo_for_the_analysis_of_clinical_trials"},{"id":50595672,"url":"https://www.researchgate.net/publication/50595672_A_Double-Blind_Placebo-Controlled_Study_of_Atomoxetine_in_Young_Children_With_ADHD"},{"id":221728915,"url":"https://www.researchgate.net/publication/221728915_A_SMART_Design_for_Building_Individualized_Treatment_Sequences"},{"id":51037355,"url":"https://www.researchgate.net/publication/51037355_The_use_of_group_sequential_information-based_sample_size_re-estimation_in_the_design_of_the_PRIMO_study_of_chronic_kidney_disease"},{"id":220504946,"url":"https://www.researchgate.net/publication/220504946_Repeated_Confidence_Intervals_Under_Fractional_Brownian_Motion_in_Long-Term_Clinical_Trials"},{"id":51074922,"url":"https://www.researchgate.net/publication/51074922_Group_sequential_and_adaptive_designs_A_novel_promising_tool_for_nursing_research"},{"id":49775581,"url":"https://www.researchgate.net/publication/49775581_An_evaluation_of_a_Simon_2-Stage_phase_II_clinical_trial_design_incorporating_toxicity_monitoring"},{"id":49759512,"url":"https://www.researchgate.net/publication/49759512_Reducing_sample_sizes_in_two-stage_phase_II_cancer_trials_by_using_continuous_tumour_shrinkage_endpoints"},{"id":220219469,"url":"https://www.researchgate.net/publication/220219469_A_method_for_calculation_of_optimum_data_size_and_bin_size_of_histogram_features_in_fault_diagnosis_of_mono-block_centrifugal_pump"},{"id":51211386,"url":"https://www.researchgate.net/publication/51211386_Continuous_safety_monitoring_for_randomized_controlled_clinical_trials_with_blinded_treatment_information_Part_3_Design_considerations"},{"id":51216562,"url":"https://www.researchgate.net/publication/51216562_Single-Injection_Depot_Progesterone_Before_Surgery_and_Survival_in_Women_With_Operable_Breast_Cancer_A_Randomized_Controlled_Trial"},{"id":51911310,"url":"https://www.researchgate.net/publication/51911310_A_General_Framework_for_Sequential_and_Adaptive_Methods_in_SurvivalStudies"},{"id":51234803,"url":"https://www.researchgate.net/publication/51234803_Simulation_methods_to_estimate_design_power_An_overview_for_applied_research"},{"id":51073589,"url":"https://www.researchgate.net/publication/51073589_Group-Sequential_Methods_for_Adaptive_Seamless_Phase_IIIII_Clinical_Trials"},{"id":51073590,"url":"https://www.researchgate.net/publication/51073590_On_Sample_Size_Determination_in_Multi-Armed_Confirmatory_Adaptive_Designs"},{"id":241742306,"url":"https://www.researchgate.net/publication/241742306_Construction_of_an_Optimal_Sequential_Plan_for_Testing_a_Treatment_for_an_Adverse_Effect"},{"id":51478752,"url":"https://www.researchgate.net/publication/51478752_SAE_An_R_package_for_early_stopping_rules_in_clinical_trials"},{"id":51077361,"url":"https://www.researchgate.net/publication/51077361_Stochastic_curtailment_of_health_questionnaires_A_method_to_reduce_respondent_burden_Statistics_in_Medicine_30_1989-2004"},{"id":251477989,"url":"https://www.researchgate.net/publication/251477989_Core_materials_development_for_the_fuel_cycle_RD_program"},{"id":241072472,"url":"https://www.researchgate.net/publication/241072472_Fracture_mechanics_behavior_of_the_T91_martensitic_steel_in_contact_with_liquid_lead-bismuth_eutectic_for_application_in_an_accelerator_driven_system"},{"id":226855702,"url":"https://www.researchgate.net/publication/226855702_Sequential_Designs_for_Clinical_Trials"},{"id":51144855,"url":"https://www.researchgate.net/publication/51144855_Perspectives_on_genome-wide_multi-stage_family-based_association_studies"},{"id":51613816,"url":"https://www.researchgate.net/publication/51613816_Efficiency_Perspectives_on_Adaptive_Designs_in_Stroke_Clinical_Trials"},{"id":51770665,"url":"https://www.researchgate.net/publication/51770665_Continuation_of_Quetiapine_Versus_Switching_to_Placebo_or_Lithium_for_Maintenance_Treatment_of_Bipolar_I_Disorder_Trial_144_A_Randomized_Controlled_Study"},{"id":51725721,"url":"https://www.researchgate.net/publication/51725721_False-Positive_Psychology"},{"id":51795056,"url":"https://www.researchgate.net/publication/51795056_Phase_I-II_Study_of_Clofarabine-Melphalan-Alemtuzumab_Conditioning_for_Allogeneic_Hematopoietic_Cell_Transplantation"},{"id":51817510,"url":"https://www.researchgate.net/publication/51817510_Adjuvant_Capecitabine_Docetaxel_Cyclophosphamide_and_Epirubicin_for_Early_Breast_Cancer_Final_Analysis_of_the_Randomized_FinXX_Trial"},{"id":266106981,"url":"https://www.researchgate.net/publication/266106981_Recall_Rate_Reduction_with_Tomosynthesis_During_Baseline_Screening_Examinations_An_Assessment_From_a_Prospective_Trial"},{"id":262835836,"url":"https://www.researchgate.net/publication/262835836_Controlling_type_I_errors_for_two-stage_bioequivalence_study_designs"},{"id":251297082,"url":"https://www.researchgate.net/publication/251297082_A_Note_on_Correction_of_Information_Time_in_a_Survival_Trial_Using_an_Alpha_Spending_Function"},{"id":51817376,"url":"https://www.researchgate.net/publication/51817376_Comments_on_'Adaptive_increase_in_sample_size_when_interim_results_are_promising_A_practical_guide_with_examples'"},{"id":51865001,"url":"https://www.researchgate.net/publication/51865001_On-pump_versus_off-pump_coronary_artery_bypass_surgery_in_high-risk_patients_Operative_results_of_a_prospective_randomized_trial_on-off_study"},{"id":51984103,"url":"https://www.researchgate.net/publication/51984103_Significance_of_a_new_fluorodeoxyglucose-positive_lesion_on_restaging_positron_emission_tomographycomputed_tomography_after_induction_therapy_for_non-small-cell_lung_cancer"},{"id":221764126,"url":"https://www.researchgate.net/publication/221764126_A_protocol_for_active_surveillance_of_acute_myocardial_infarction_in_association_with_the_use_of_a_new_antidiabetic_pharmaceutical_agent"},{"id":221764102,"url":"https://www.researchgate.net/publication/221764102_Challenges_in_the_design_and_analysis_of_sequentially_monitored_postmarket_safety_surveillance_evaluations_using_electronic_observational_health_care_data_Pharmacoepidemiol_Drug_Safety"},{"id":258385063,"url":"https://www.researchgate.net/publication/258385063_Methodology_and_Application_of_Adaptive_and_Sequential_Approaches_in_Contemporary_Clinical_Trials"},{"id":51871890,"url":"https://www.researchgate.net/publication/51871890_Curtailed_two-stage_designs_with_two_dependent_binary_endpoints"},{"id":258306929,"url":"https://www.researchgate.net/publication/258306929_The_US_Food_and_Drug_Administration's_Mini-Sentinel_Program"},{"id":278318075,"url":"https://www.researchgate.net/publication/278318075_Monitoring_Randomized_Clinical_Trials"},{"id":281589771,"url":"https://www.researchgate.net/publication/281589771_Sequential_Statistical_Methods_for_Prospective_PostMarketing_Safety_Surveillance"},{"id":221771983,"url":"https://www.researchgate.net/publication/221771983_Dose-Intensification_in_Early_Unfavorable_Hodgkin's_Lymphoma_Final_Analysis_of_the_German_Hodgkin_Study_Group_HD14_Trial"},{"id":51703200,"url":"https://www.researchgate.net/publication/51703200_Hybridization_of_conditional_and_predictive_power_for_futility_assessment_in_sequential_clinical_trials_with_time-to-event_outcomes_A_resampling_approach"},{"id":221721815,"url":"https://www.researchgate.net/publication/221721815_Effects_of_a_single_topical_doxycycline_administration_adjunctive_to_mechanical_debridement_in_patients_with_persistentrecurrent_periodontitis_but_acceptable_oral_hygiene_during_supportive_periodontal"},{"id":51851967,"url":"https://www.researchgate.net/publication/51851967_Optimal_multistage_designs_for_randomised_clinical_trials_with_continuous_outcomes"},{"id":221785326,"url":"https://www.researchgate.net/publication/221785326_Interim_analysis_in_clinical_trials"},{"id":221753208,"url":"https://www.researchgate.net/publication/221753208_Stopping_Guidelines_for_Harm_in_a_Study_Designed_to_Establish_the_Safety_of_a_Marketed_Drug"},{"id":221721448,"url":"https://www.researchgate.net/publication/221721448_Culturable_Gut_Microbiota_Diversity_in_Zebrafish"},{"id":221735536,"url":"https://www.researchgate.net/publication/221735536_Operating_characteristics_of_a_Simon_two-stage_phase_II_clinical_trial_design_incorporating_continuous_toxicity_monitoring"},{"id":225184797,"url":"https://www.researchgate.net/publication/225184797_More_Efficient_Ways_of_Assessing_Treatments_for_Neglected_Tropical_Diseases_Are_Required_Innovative_Study_Designs_New_Endpoints_and_Markers_of_Effects"},{"id":233410498,"url":"https://www.researchgate.net/publication/233410498_The_Revised_2010_EMA_Guideline_for_the_Investigation_of_Bioequivalence_for_Immediate_Release_Oral_Formulations_with_Systemic_Action"},{"id":234162173,"url":"https://www.researchgate.net/publication/234162173_Evaluating_the_Effect_of_Early_Versus_Late_ARV_Regimen_Change_if_Failure_on_an_Initial_Regimen_Results_From_the_AIDS_Clinical_Trials_Group_Study_A5095"},{"id":227711336,"url":"https://www.researchgate.net/publication/227711336_Protecting_Clinical_Trial_Participants_and_Protecting_Data_Integrity_Are_We_Meeting_the_Challenges"},{"id":257338118,"url":"https://www.researchgate.net/publication/257338118_Group_sequential_comparison_of_two_binomial_proportions_under_ranked_set_sampling_design"},{"id":225085184,"url":"https://www.researchgate.net/publication/225085184_Optimization_of_adaptive_designs_Efficiency_evaluation"},{"id":225085185,"url":"https://www.researchgate.net/publication/225085185_Adaptive_group_sequential_test_with_changing_patient_population"},{"id":228105375,"url":"https://www.researchgate.net/publication/228105375_Overestimation_of_the_Effect_Size_in_Group_Sequential_Trials"},{"id":221967144,"url":"https://www.researchgate.net/publication/221967144_Testing_superiority_at_interim_analyses_in_a_non-inferiority_trial"},{"id":228063851,"url":"https://www.researchgate.net/publication/228063851_Adaptive_extensions_of_a_two-stage_group_sequential_procedure_for_testing_primary_and_secondary_endpoints_I_Unknown_correlation_between_the_endpoints"},{"id":228066914,"url":"https://www.researchgate.net/publication/228066914_Adaptive_extensions_of_a_two-stage_group_sequential_procedure_for_testing_primary_and_secondary_endpoints_II_Sample_size_re-estimation"},{"id":260413129,"url":"https://www.researchgate.net/publication/260413129_Interim_analysis_of_clinical_trials_based_on_urn_models"},{"id":230812219,"url":"https://www.researchgate.net/publication/230812219_A_Practical_Simulation_Method_to_Calculate_Sample_Size_of_Group_Sequential_Trials_for_Time-to-Event_Data_under_Exponential_and_Weibull_Distribution"},{"id":230763133,"url":"https://www.researchgate.net/publication/230763133_Current_issues_in_clinical_trials_Standing_on_the_shoulders_of_Jerome_Cornfield"},{"id":234085599,"url":"https://www.researchgate.net/publication/234085599_Application_of_Adaptive_Design_Methodology_in_Development_of_a_Long-Acting_Glucagon-like_Peptide-1_Analog_Dulaglutide_Statistical_Design_and_Simulations"},{"id":232699052,"url":"https://www.researchgate.net/publication/232699052_Efficacy_of_an_Absorbable_Fibrin_Sealant_Patch_TachoSil_After_Distal_Pancreatectomy"},{"id":263451159,"url":"https://www.researchgate.net/publication/263451159_Spending_functions_and_continuous-monitoring_boundaries"},{"id":233805412,"url":"https://www.researchgate.net/publication/233805412_Phase_I_evaluation_of_the_effects_of_ketoconazole_and_rifampicin_on_cediranib_pharmacokinetics_in_patients_with_solid_tumours"},{"id":263271033,"url":"https://www.researchgate.net/publication/263271033_Modelling_and_simulating_early_stopping_of_RCTs_A_case_study_of_early_stop_due_to_harm"},{"id":233930827,"url":"https://www.researchgate.net/publication/233930827_Some_recommendations_for_multi-arm_multi-stage_trials"},{"id":263759661,"url":"https://www.researchgate.net/publication/263759661_Optimal_design_of_multi-arm_multi-stage_trials"},{"id":264341831,"url":"https://www.researchgate.net/publication/264341831_Group_sequential_tests_for_delayed_responses_with_discussion_Group_Sequential_Tests"},{"id":265703049,"url":"https://www.researchgate.net/publication/265703049_Statistical_Methods_for_Dynamic_Treatment_Regimes_Reinforcement_Learning_Causal_Inference_and_Personalized_Medicine"},{"id":279353726,"url":"https://www.researchgate.net/publication/279353726_Springer_Series_in_Statistics"},{"id":279367479,"url":"https://www.researchgate.net/publication/279367479_Adaptive_Design_of_Confirmatory_Trials"},{"id":234070636,"url":"https://www.researchgate.net/publication/234070636_Adapting_Group_Sequential_Methods_to_Observational_Postlicensure_Vaccine_Safety_Surveillance_Results_of_a_Pentavalent_Combination_DTaP-IPV-Hib_Vaccine_Safety_Study"},{"id":234087097,"url":"https://www.researchgate.net/publication/234087097_Comparison_of_Digital_Mammography_Alone_and_Digital_Mammography_Plus_Tomosynthesis_in_a_Population-based_Screening_Program"},{"id":268069578,"url":"https://www.researchgate.net/publication/268069578_Biometrika_highlights_from_volume_28_onwards"},{"id":235727669,"url":"https://www.researchgate.net/publication/235727669_Power_Comparisons_for_Group_Sequential_Tests_with_Nonparametric_Statistics_in_Case_of_Nonproportional_Hazards"},{"id":235630415,"url":"https://www.researchgate.net/publication/235630415_Early_termination_of_a_two-stage_study_to_develop_and_validate_a_panel_of_biomarkers"},{"id":235943568,"url":"https://www.researchgate.net/publication/235943568_PHOENIX_protocol"},{"id":232741887,"url":"https://www.researchgate.net/publication/232741887_Considerations_on_covariates_and_endpoints_in_multi-arm_multi-stage_clinical_trials_selecting_all_promisingtreatments"},{"id":233914711,"url":"https://www.researchgate.net/publication/233914711_A_group_sequential_Holm_procedure_with_multiple_primary_endpoints"},{"id":236139975,"url":"https://www.researchgate.net/publication/236139975_An_Insight_into_the_Properties_of_a_Two-Stage_Design_in_Bioequivalence_Studies"},{"id":269476289,"url":"https://www.researchgate.net/publication/269476289_A_Practical_Guide_to_Data_Monitoring_Committees_in_Adaptive_Trials"},{"id":236600035,"url":"https://www.researchgate.net/publication/236600035_Prophylactic_Efficacy_of_Oral_Emtricitabine_FTC_and_Tenofovir_Disoproxil_Fumarate_TDF_Combination_Against_A_Tenofovir-Resistant_Shiv_Containing_the_K65R_Mutation_in_Macaques"},{"id":263729345,"url":"https://www.researchgate.net/publication/263729345_A_note_on_variance_estimation_in_the_Cox_proportional_hazards_model"},{"id":236339495,"url":"https://www.researchgate.net/publication/236339495_Multiple_comparisons_in_complex_clinical_trial_designs"},{"id":236676278,"url":"https://www.researchgate.net/publication/236676278_Advancing_clinical_trial_design_in_pulmonary_hypertension"},{"id":234124610,"url":"https://www.researchgate.net/publication/234124610_A_Bayesian_decision-theoretic_sequential_response-adaptive_randomization_design"},{"id":257810158,"url":"https://www.researchgate.net/publication/257810158_Robust_Bayesian_monitoring_of_sequential_trials"},{"id":239943887,"url":"https://www.researchgate.net/publication/239943887_Type_I_Error_in_Headache_Research"},{"id":263345729,"url":"https://www.researchgate.net/publication/263345729_Asymmetric_Group_Sequential_Designs_under_Fractional_Brownian_Motion"},{"id":264997194,"url":"https://www.researchgate.net/publication/264997194_Sequential_Testing_of_Measurement_Errors_in_Inter-Rater_Reliability_Studies"},{"id":244992555,"url":"https://www.researchgate.net/publication/244992555_International_Guidelines_for_Bioequivalence_of_Systemically_Available_Orally_Administered_Generic_Drug_Products_A_Survey_of_Similarities_and_Differences"},{"id":245028195,"url":"https://www.researchgate.net/publication/245028195_Monitoring_in_clinical_trials_Benefit_or_bias"},{"id":250919506,"url":"https://www.researchgate.net/publication/250919506_The_effects_of_umbilical_cord_milking_in_extremely_preterm_infants_A_randomized_controlled_trial"},{"id":257406166,"url":"https://www.researchgate.net/publication/257406166_Group_sequential_methods_based_on_ranked_set_samples"},{"id":270002531,"url":"https://www.researchgate.net/publication/270002531_On_the_Use_of_Local_Assessments_for_Monitoring_Centrally_Reviewed_Endpoints_with_Missing_Data_in_Clinical_Trials"},{"id":255953873,"url":"https://www.researchgate.net/publication/255953873_Night_glucose_control_with_MD-Logic_artificial_pancreas_in_home_setting_A_single_blind_randomized_crossover_trial-interim_analysis"},{"id":265764464,"url":"https://www.researchgate.net/publication/265764464_Interim_monitoring_of_clinical_trials_Decision_theory_dynamic_programming_and_optimal_stopping"},{"id":259203641,"url":"https://www.researchgate.net/publication/259203641_Sequential_Analysis_of_the_Cox_Model_under_Response_Dependent_Allocation"},{"id":271759186,"url":"https://www.researchgate.net/publication/271759186_Multiple_Testing_in_Group_Sequential_Trials_Using_Graphical_Approaches"},{"id":262798683,"url":"https://www.researchgate.net/publication/262798683_Reducing_the_average_number_of_patients_needed_in_a_phase_II_trial_through_novel_design"},{"id":258953599,"url":"https://www.researchgate.net/publication/258953599_Achieving_Integration_in_Mixed_Methods_Designs-Principles_and_Practices"},{"id":259253372,"url":"https://www.researchgate.net/publication/259253372_Randomized_Placebo-Controlled_Phase_III_Trial_of_Sunitinib_Plus_Prednisone_Versus_Prednisone_Alone_in_Progressive_Metastatic_Castration-Resistant_Prostate_Cancer"},{"id":270671670,"url":"https://www.researchgate.net/publication/270671670_Adaptive_Clinical_Trials_Overview_of_Phase_III_Designs_and_Challenges"},{"id":273923834,"url":"https://www.researchgate.net/publication/273923834_Advances_in_Statistical_Approaches_Oncology_Drug_Development"},{"id":265421236,"url":"https://www.researchgate.net/publication/265421236_Lenalidomide_and_Dexamethasone_in_Transplant-Ineligible_Patients_with_Multiple_Myeloma"},{"id":268506359,"url":"https://www.researchgate.net/publication/268506359_Developments_in_statistical_evaluation_of_clinical_trials"},{"id":259607495,"url":"https://www.researchgate.net/publication/259607495_Adaptive_designs_with_arbitrary_dependence_structure"},{"id":273118151,"url":"https://www.researchgate.net/publication/273118151_Clinical_Development_Approaches_and_Statistical_Methodologies_to_Prospectively_Assess_the_Cardiovascular_Risk_of_New_Antidiabetic_Therapies_for_Type_2_Diabetes"},{"id":277697834,"url":"https://www.researchgate.net/publication/277697834_Group_Sequential_Tests_for_Treatment_Effect_with_Covariates_Adjustment_through_Simple_Cross-Effect_Models"},{"id":263716887,"url":"https://www.researchgate.net/publication/263716887_Unbalanced_and_Partial_Group_Sequential_Methods_for_Normal_Responses_in_Clinical_Trials"},{"id":263613420,"url":"https://www.researchgate.net/publication/263613420_Flexibly_Monitoring_Group_Sequential_Survival_Trials_When_Testing_Is_Based_Upon_a_Weighted_Log-Rank_Statistic"},{"id":281401711,"url":"https://www.researchgate.net/publication/281401711_Fuzzy_approach_of_group_sequential_test_for_binomial_case"},{"id":261924534,"url":"https://www.researchgate.net/publication/261924534_An_Evaluation_of_Inferential_Procedures_for_Adaptive_Clinical_Trial_Designs_with_Pre-specified_Rules_for_Modifying_the_Sample_Size"},{"id":289412579,"url":"https://www.researchgate.net/publication/289412579_Recent_Developments_in_Group-Sequential_Designs"},{"id":287028489,"url":"https://www.researchgate.net/publication/287028489_Designing_Multi-arm_Multi-stage_Clinical_Studies"},{"id":262642766,"url":"https://www.researchgate.net/publication/262642766_Higher_order_response-adaptive_urn_designs_for_clinical_trials_with_highly_successful_treatments"},{"id":275477618,"url":"https://www.researchgate.net/publication/275477618_An_Ethical_Approach_to_Peeking_at_Data"},{"id":262695419,"url":"https://www.researchgate.net/publication/262695419_The_utility_of_Bayesian_predictive_probabilities_for_interim_monitoring_of_clinical_trials"},{"id":263099424,"url":"https://www.researchgate.net/publication/263099424_Adaptive_Sequential_Testing_for_Multiple_Comparisons"},{"id":263899157,"url":"https://www.researchgate.net/publication/263899157_Interim_analysis_for_binary_outcome_trials_with_a_long_fixed_follow-up_time_and_repeated_outcome_assessments_at_pre-specified_times"},{"id":270098489,"url":"https://www.researchgate.net/publication/270098489_A_Bayesian_Stopping_Rule_for_Sequential_Monitoring_of_Serious_Adverse_Events"},{"id":261141666,"url":"https://www.researchgate.net/publication/261141666_Sample_size_determination_in_group-sequential_clinical_trials_with_two_co-primary_endpoints"},{"id":261293889,"url":"https://www.researchgate.net/publication/261293889_Continuous_sequential_boundaries_for_vaccine_safety_surveillance"},{"id":265389219,"url":"https://www.researchgate.net/publication/265389219_Bayesian_designs_and_the_control_of_frequentist_characteristics_A_practical_solution_Bayesian_Designs_and_the_Control_of_Frequentist_Characteristics_A_Practical_Solution"},{"id":265968583,"url":"https://www.researchgate.net/publication/265968583_Group_sequential_method_for_observational_data_by_using_generalized_estimating_equations_Application_to_Vaccine_Safety_Datalink"},{"id":267755760,"url":"https://www.researchgate.net/publication/267755760_Lenalidomide_and_Dexamethasone_in_Transplant-Ineligible_Patients_with_Myeloma"},{"id":265733281,"url":"https://www.researchgate.net/publication/265733281_A_multi-stage_drop-the-losers_design_for_multi-arm_clinical_trials"},{"id":266623730,"url":"https://www.researchgate.net/publication/266623730_Methodological_choices_for_the_clinical_development_of_medical_devices"},{"id":266249402,"url":"https://www.researchgate.net/publication/266249402_Challenge_and_Opportunity_in_Evaluating_a_Diffusion-Based_Active_Bystanding_Prevention_Program_Green_Dot_in_High_Schools"},{"id":263893928,"url":"https://www.researchgate.net/publication/263893928_Randomized_Trial_of_Fish_Oil_Infusion_to_Prevent_Atrial_Fibrillation_After_Cardiac_Surgery_Data_From_an_Implantable_Continuous_Cardiac_Monitor"},{"id":263701497,"url":"https://www.researchgate.net/publication/263701497_Bioequivalence_study_with_lapatinib_powder_for_oral_suspension_and_the_original_tablet_formulation_in_cancer_patients_Clinical_Pharmacology_in_Drug_Development"},{"id":268451383,"url":"https://www.researchgate.net/publication/268451383_The_Effects_of_Probiotic_Supplementation_on_Markers_of_Blood_Lipids_and_Blood_Pressure_in_Patients_with_Prediabetes_A_Randomized_Clinical_Trial"},{"id":266975570,"url":"https://www.researchgate.net/publication/266975570_Group_Sequential_Design_for_Randomized_Phase_III_Trials_under_the_Weibull_Model"},{"id":267747177,"url":"https://www.researchgate.net/publication/267747177_Quality_Assurance_Test_of_Delivered_Dose_Uniformity_of_Multiple-Dose_Inhaler_and_Dry_Powder_Inhaler_Drug_Products"},{"id":272370255,"url":"https://www.researchgate.net/publication/272370255_A_randomized_trial_of_continuous_versus_interrupted_chest_compressions_in_out-of-hospital_cardiac_arrest_Rationale_for_and_design_of_the_Resuscitation_Outcomes_Consortium_Continuous_Chest_Compressions"},{"id":264546886,"url":"https://www.researchgate.net/publication/264546886_CP_function_An_alpha_spending_function_based_on_conditional_power"},{"id":268986297,"url":"https://www.researchgate.net/publication/268986297_Hematopoietic_cell_transplantation_in_patients_with_intermediate_and_high-risk_AML_results_from_the_randomized_Study_Alliance_Leukemia_SAL_AML_2003_trial"},{"id":269636825,"url":"https://www.researchgate.net/publication/269636825_Simulation_study_comparing_exposure_matching_with_regression_adjustment_in_an_observational_safety_setting_with_group_sequential_monitoring"},{"id":260779836,"url":"https://www.researchgate.net/publication/260779836_Performing_High-Powered_Studies_Efficiently_With_Sequential_Analyses"},{"id":265689990,"url":"https://www.researchgate.net/publication/265689990_Violations_of_the_independent_increment_assumption_when_using_generalized_estimating_equation_in_longitudinal_group_sequential_trials"},{"id":270005233,"url":"https://www.researchgate.net/publication/270005233_Effect_of_Depth_and_Duration_of_Cooling_on_Deaths_in_the_NICU_Among_Neonates_With_Hypoxic_Ischemic_Encephalopathy_A_Randomized_Clinical_Trial"},{"id":267715240,"url":"https://www.researchgate.net/publication/267715240_The_effect_of_horizontal_eye_movements_on_free_recall_A_preregistered_adversarial_collaboration"},{"id":267734164,"url":"https://www.researchgate.net/publication/267734164_Allocating_recycled_significance_levels_in_group_sequential_procedures_for_multiple_endpoints"},{"id":273298591,"url":"https://www.researchgate.net/publication/273298591_Group-Sequential_Strategies_in_Clinical_Trials_with_Multiple_Co-Primary_Outcomes"},{"id":271223035,"url":"https://www.researchgate.net/publication/271223035_Two-stage_designs_in_bioequivalence_trials"},{"id":271597042,"url":"https://www.researchgate.net/publication/271597042_Independent_data_monitoring_committees_An_update_and_overview"},{"id":272395075,"url":"https://www.researchgate.net/publication/272395075_Efficient_Score_Statistic_in_Drug_and_Vaccine_Safety_Surveillance"},{"id":273153418,"url":"https://www.researchgate.net/publication/273153418_A_multi-site_randomized_clinical_trial_to_reduce_suicidal_ideation_in_suicidal_adult_outpatients_with_Major_Depressive_Disorder_Development_of_a_methodology_to_enhance_safety"},{"id":274197001,"url":"https://www.researchgate.net/publication/274197001_Longitudinal_clinical_trials_with_adaptive_choice_of_follow-up_time"},{"id":274089360,"url":"https://www.researchgate.net/publication/274089360_Moderne_Studiendesigns_und_Analysemethoden_in_der_klinischen_Forschung"},{"id":273524925,"url":"https://www.researchgate.net/publication/273524925_Multistage_Adaptive_Biomarker-Directed_Targeted_Design_for_Randomized_Clinical_Trials"},{"id":274092617,"url":"https://www.researchgate.net/publication/274092617_Two-stage_designs_for_cross-over_bioequivalence_trials"},{"id":276481536,"url":"https://www.researchgate.net/publication/276481536_Early_stopping_of_RCTs_two_potential_issues_for_error_statistics"},{"id":279736000,"url":"https://www.researchgate.net/publication/279736000_The_Influence_of_Biostatistics_at_the_National_Heart_Lung_and_Blood_Institute"},{"id":275278112,"url":"https://www.researchgate.net/publication/275278112_Donepezil_for_Irradiated_Brain_Tumor_Survivors_A_Phase_III_Randomized_Placebo-Controlled_Clinical_Trial"},{"id":277024610,"url":"https://www.researchgate.net/publication/277024610_Continuous_versus_group_sequential_analysis_for_post-market_drug_and_vaccine_safety_surveillance"},{"id":275717203,"url":"https://www.researchgate.net/publication/275717203_Clinical_trialist_perspectives_on_the_ethics_of_adaptive_clinical_trials_A_mixed-methods_analysis_Ethics_in_Biomedical_Research"},{"id":279189119,"url":"https://www.researchgate.net/publication/279189119_Trial_Sequential_Meta-analysis"},{"id":280913122,"url":"https://www.researchgate.net/publication/280913122_Flexible_risk-adjusted_surveillance_procedures_for_autocorrelated_binary_series"},{"id":282953246,"url":"https://www.researchgate.net/publication/282953246_OptGS_An_R_Package_for_Finding_Near-Optimal_Group-Sequential_Designs"},{"id":280871148,"url":"https://www.researchgate.net/publication/280871148_Best_but_oft-forgotten_practices_The_multiple_problems_of_multiplicity-whether_and_how_to_correct_for_many_statistical_tests"},{"id":281621606,"url":"https://www.researchgate.net/publication/281621606_Opportunistic_Biases_Their_Origins_Effects_and_an_Integrated_Solution"},{"id":282043542,"url":"https://www.researchgate.net/publication/282043542_Enrollment_and_Stopping_Rules_for_Managing_Toxicity_Requiring_Long_Follow-Up_in_Phase_II_Oncology_Trials"},{"id":282583534,"url":"https://www.researchgate.net/publication/282583534_Adaptive_Designs_with_Discrete_Test_Statistics_and_Consideration_of_Overrunning"},{"id":283494417,"url":"https://www.researchgate.net/publication/283494417_An_Investigation_of_the_Shortcomings_of_the_CONSORT_2010_Statement_for_the_Reporting_of_Group_Sequential_Randomised_Controlled_Trials_A_Methodological_Systematic_Review"},{"id":285234319,"url":"https://www.researchgate.net/publication/285234319_Power_Analysis_and_Sample_Sizes_A_Binding_Frontier_Approach"},{"id":284171896,"url":"https://www.researchgate.net/publication/284171896_Systematic_Reviews_of_Anesthesiologic_Interventions_Reported_as_Statistically_Significant_Problems_with_Power_Precision_and_Type_1_Error_Protection"}],"reference":["https://www.researchgate.net/publication/18567420_Group_Sequential_Designs_for_Clinical_Trials","https://www.researchgate.net/publication/216301101_Repeated_Significance_Tests_on_Accumulating_Data_when_the_Null_Hypothesis_is_not_True","https://www.researchgate.net/publication/216300067_Repeated_Significance_Tests_on_Accumulating_Data"]}